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ABSTRACT 
INTRODUCTION 
Ventilator Associated Pneumonia (VAP) is one of the common nosocomial infections in 
ICU. VAP is the second leading cause of morbidity and mortality in the intensive care unit after 
urinary tract infection. The incidence of VAP was 86% and mortality rates exceed 59%. Once 
the patient has developed VAP, additional requirement of treatment increases the length of stay 
by up to 22 days and raise the cost of care. 86% of nosocomial pneumonia was associated with 
intubation and mechanical ventilation. 
STATEMENT OF THE PROBLEM 
A Study to evaluate the impact of comprehensive interventional package to identify the 
risk of ventilator associated pneumonia among ventilated patients in selected hospital, Madurai. 
OBJECTIVES 
Objectives of the study were to; 
1. To assess the risk of ventilator associated pneumonia before and after implementation of 
comprehensive interventional package among patients in control and experimental group. 
2. To determine the impact of comprehensive interventional package on ventilator 
associated pneumonia risk by comparing pre-test and post-test scores among control and 
experimental group. 
3. To determine the impact of comprehensive interventional package on ventilator 
associated pneumonia risk by comparing post-test scores between the control and 
experimental group. 
4. To find out the association between the risks of ventilator associated pneumonia among 
ventilated patients with their selected demographic and clinical variables in control and 
experimental group. 
MATERIAL AND METHODS 
In this study, quasi experimental pre-test post-test control group design was adopted. The 
researcher has chosen two hospitals which include Vadamalayan hospital and Velammal medical 
college hospital from Madurai, Tamil Nadu as experimental group and control group 
respectively for the present study. The sample comprised of 60 ventilated patients at selected 
hospitals in Madurai, among which 30 patients were assigned in the control group and 30 
patients were in the experimental group.  The samples were recognized based on the inclusion 
criteria and selected by convenience sampling technique. Risk assessment tool for VAP was used 
as a tool for data collection after confirming validity and reliability. Comprehensive 
interventional package was implemented on the experimental group only. The data obtained was 
analyzed and interpreted using descriptive and inferential statistics. 
RESULTS 
The score of the modified clinical pulmonary score for risk of ventilator associated 
pneumonia were compared within the groups. The findings revealed that, In the experimental 
group, Out of the total 30 patients after the implementation of comprehensive interventional 
package, in the pre-test majority of the patient 27 (90%) had mild risk, 3 (10%) had no risk and 
none had moderate or high risk. Whereas in the post-test-1 most of the patients 24 (80%) had 
mild risk, 2 (6.66%) had no risk, 4 (13.33%) had moderate risk and none had high risk. Similarly 
in the post-test-2 majority of patients 24 (80%) had mild risk, 3 (10%) had moderate risk, 3 
(10%) had no risk and none had high risk. The risk of Ventilated Associated Pneumonia risk 
score in pre-test was 1.83, post-test-1 was 2.3 and the post-test-2 was 2.13. The paired ‘t’ test  for 
the risk of ventilated associated pneumonia was 3.58, 1.8 and 8.136, which shows there is no 
raise in the risk of Ventilated Associated Pneumonia  in the pre-test, post-test-1 and post-test-2 
among experimental group after the implementation of comprehensive interventional package. 
Whereas in the control group, Out of the total 30 patients, in the pre-test relatively a high 
proportion of the patients 27 (90%) had mild risk, 3 (10%) had no risk and none of them had 
moderate or high risk. Whereas in the post-test-1 majority of the patient 16 (53.33%) had 
moderate risk, 14 (46.66%) had mild risk and none of them had no risk or high risk. Whereas in 
post-test-2 most of the patient 18 (60%) had moderate risk, 6 (20%) had high risk, 6 (20%) had 
mild risk and none of them had no risk.The risk of Ventilated Associated Pneumonia risk score 
in pre-test was 1.73, post-test-1 was 3.23 and the post-test-2 was 25.36. The paired ‘t’ test  for 
the risk of ventilated associated pneumonia was 7.14, 7.56 and 5.38, which shows there is raise 
in the risk of Ventilated Associated Pneumonia  in the pre-test, post-test-1 and post-test-2 among 
control group without the implementation of comprehensive interventional package. 
It can be interpreted that the risk of ventilator Associated Pneumonia has not increased in 
the experimental after the implementation of comprehensive interventional package. 
Regarding the impact of comprehensive interventional package, the mean score for post-
test-2 was lower than the mean score for post-test-1. It was 2.3 in the post-test-1 and 2.13 in the 
post-test-2. The paired ‘t’ test for the risk of Ventilator Associated Pneumonia was 5.38 
(p<0.001), which was highly significant. The independent ‘t’ test was 8.136 (p<0.001), which 
was highly significant. This was statistically proven that the impact of comprehensive 
interventional package on risk of Ventilator Associated Pneumonia was effective among 
mechanically ventilated patients.  
Regarding association between the pre-test risk of Ventilated Associated Pneumonia with 
the selected socio-demographic and clinical variables, there is no significant association between 
the risk of Ventilator Associated Pneumonia with the selected socio-demographic and clinical 
variables. 
DISCUSSION 
In this study the risk of ventilator associated pneumonia among mechanically ventilated 
patients was assessed and it showed that the ventilated clients are at high risk for developing 
ventilator associated pneumonia. Comprehensive interventional package was used as a means for 
preventing the risk of ventilator associated pneumonia among ventilated patients. Thus, the 
finding of this study provides an empirical evidence to prove that the implementation of 
comprehensive interventional package is a good method to prevent the risk of Ventilator 
Associated Pneumonia among the mechanically ventilated patients. 
CONCLUSION 
The study results reveal that, there is significant difference in the risk of ventilator 
associated pneumonia in experimental and control group. The study concluded that the 
implementation of comprehensive interventional package was effective in preventing the risk of 
ventilator associated pneumonia among mechanically ventilated patients. 
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CHAPTER I 
INTRODUCTION 
“An ounce of prevention is worth a pound of cure” 
- Benjamin Franklin 
BACKGROUND OF THE STUDY 
The health care providers and patient face multiple challenges, where new treatment 
modalities and technology interfere with the continuing efforts to strive for quality care and 
expected outcomes. Efficiency and cost effectiveness must go hand in hand, to satisfy the 
patients and to improve the quality of care. While encouraging the innovations, it makes a sense; 
their drastic effects need to be screened. 
Ventilator Associated Pneumonia (VAP) is one of the common nosocomial infections in 
ICU. VAP is the second leading cause of morbidity and mortality in the intensive care unit after 
urinary tract infection. The incidence of VAP was 86% and mortality rates exceed 59%. Once 
the patient has developed VAP, additional requirement of treatment increases the length of stay 
by up to 22 days and raise the cost of care. 86% of nosocomial pneumonia was associated with 
intubation and mechanical ventilation. The most frequent isolates from pneumonia were Gram-
negative aerobic organisms (64%) such as Pseudomonas Aeruginosa (21%) and Acinetobacter 
(18%). Staphylococcus aureus (20%) was also isolated with similar frequency, among 
hospitalized patients in United States (Mehta et al. 2003). 
According to global statistics, 8.7% of patients with Hospital acquired infection has 
mortality rate as high as 50%. Ventilator associated pneumonia is the most common Hospital 
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acquired infection among mechanically ventilated patients worldwide, is a major clinical 
concern, associated with high incidence rates, mortality and costs in Europe, United states, and 
Asia. Ventilator associated pneumonia rates range from 9-40%, and as high as 78%. 
The incidence of VAP in ICU is 18.7 per 1000 days of mechanical ventilation. Ventilator 
associated pneumonia occurs in 9 to 27% of all intubated patients and 28 to 40% of brain injury 
in ventilated patients develops due to this condition. Ventilator associated pneumonia occurs up 
to 17 times more frequently in developing countries than elsewhere and has a mortality rate as 
high as 27%, among all other infections. The risk of VAP is higher during early course of 
hospital stay. It is estimated to be 3% during first 5 days, decreasing to 2% during 5 to 10 days of 
mechanical ventilation and to 1% afterwards. Among hospital acquired infections VAP is the 
leading cause of death, exceeding the rate of death due to central line infection, severe sepsis, 
and respiratory infection in the non-intubated patients. Hospital mortality of ventilated patients 
who develop VAP is 46%, in comparison with 32% of ventilated patients who do not develop 
VAP.  
According to Indian statistical analysis, Ventilator associated pneumonia was 24 out of 
51 cases. The mortality in the Ventilator Associated pneumonia group was 37%. The incidence 
of ventilator associated pneumonia was 8.3% of the total number of patients on ventilator 
support. The data summary for 1992-2004 from the National Nosocomial Infections Surveillance 
System report reveals a medium ventilator associated pneumonia rate 2.2 to 14.7 cases per 1000 
patient days of mechanical ventilation in adult ICUs. 
The development of sophisticated technology, support and elaborate medical 
interventions, which help many patients to walk out of the hospital, which was unimaginable a 
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few decades back. In order to gain maximum benefits out of advanced technologies, it is 
mandatory for the health care professionals to follow standard guidelines to prevent nosocomial 
infections. 
The prevalence of nosocomial infection is higher in Intensive Care Units (ICU) than in 
the general hospital wards. Catheter related infections, Ventilator Associated Pneumonia and 
surgical site infections cause the majority of these nosocomial infections. Nosocomial infection 
increases the mortality, morbidity and cost. The length of hospital stay, stay in ICU, and duration 
of mechanical ventilation are higher in those patients. Utilization of invasive devices in the major 
risk factors for the development of nosocomial infections in ICUs warrants the support of 
invasive devices. Adherence to preventive measures by ICU staff is crucial in reducing 
nosocomial infections. Implementation of evidence based infection control measures should be 
the basis for the prevention of nosocomial infection (Rello et al. 2007). 
Most episodes of ventilator associate pneumonia (VAP) are developed from the 
aspiration of oropharyngeal secretions containing potentially pathogenic organisms. Aspiration 
of gastric secretions may also contribute to the development of VAP, though likely to a lesser 
degree. Interruption of the body’s anatomic and physiology defense against aspiration by 
tracheal intubation makes mechanical ventilation a major risk factor for VAP. Patients affected 
with pulmonary infection are economically overburdened in addition to the treatment of the 
primary condition. 
VAP is a preventable secondary consequence resulting from intubation and mechanical 
ventilation. VAP can be prevented by a combination of intervention which constitutes the VAP 
bundle. VAP bundle includes head end elevation, hand hygiene, sedation holidays, Deep vein 
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Thrombosis (DVT) prophylaxis, ulcer prophylaxis and oral care. Novice aspects that can be 
included in VAP bundle in Subglottic Suctioning. Each aspect of VAP bundle is aimed to 
prevent the aspiration of secretions containing bacteria into the sterile lower respiratory tract 
(Mayhall, 2004). 
Poor oral hygiene causes the microorganism to colonize in the oropharynx. There is a 
chance of aspiration of these microorganisms to the lower respiratory tract, causing pneumonia. 
The chance of aspiration is very high among the patients who are unconscious or semiconscious, 
intubated and mechanically ventilated. Growth of potentially pathogenic bacteria in dental 
plaque provides a nidus of infection for microorganisms which result in development of VAP. 
Dental plaque provides a microhabitat for pathogenic organisms and provides opportunity for 
adherence either to the tooth surface or to other microorganisms. This microorganism in the 
mouth gets translocated and colonizes the lung, which can result in VAP. 
Removing bacteria from oropharynx requires the removal of dental plaque and proper 
oral hygiene is the only way to remove plaque. Majority of nurses use a soft toothette instead of 
tooth brushing and the toothette do not remove plaque as effective as tooth brushes, 
consequently, oral bacteria can proliferate (Berry at al. 2007). 
In normal endotracheal tube there is collection of secretion just above the cuff, which 
cannot be effectively removed by routine oral suctioning. Amount of secretion pooling above the 
cuff of endotracheal tube can be minimized by continuous or intermittent aspiration of the 
secretion which prevent micro aspiration. This can be done by the use of a special endotracheal 
tube having an additional dorsal lumen called subglottic suctioning port. 
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Use of continuous aspiration of subglottic secretions in intubated patients reduced the 
incidence of ventilator associated pneumonia by 43.4%. This decrease was caused by a 
significant reduction in the incidence of pneumonia during the initial days of mechanical 
ventilation. Subglottic suctioning represents a simple, inexpensive, and useful approach in the 
prevention of nosocomial pneumonia. It primarily reduces the risk of pneumonia, caused by 
indigenous flora already present in the oral cavity of patients at the time of intubation. 
Furthermore, this measure helps to reduce the antibiotic dosage when combined with other 
methods of prevention (Lacherade et al. 2010). 
VENTILAITOR ASSOCIATED PNEUMONIA 
Ventilator-associated pneumonia (VAP) is defined as pneumonia that occurs 48-72 hours 
of therefore following Endotracheal intubation, characterized by the presence of a new or 
progressive infiltrate, signs of systemic infection (fever, altered white blood cell count), change 
in sputum characteristic, and detection of causative agent. 
Causes of ventilator associated pneumonia are the Infectious bacteria obtain direct access 
to the lower respiratory tract via Micro, Pooling and trickling of secretions, and Impairment of 
mucociliary clearance of secretions. The most important common clinical manifestations of 
ventilator associated pneumonia are Fever or low body temperature, new purulent sputum, 
Hypoxemia (decreased amounts of oxygen in the blood) and Respiratory distress 
The preventive measures include the following: 
 Staff education 
 Clinical guidelines and care protocols 
 Infection prevention and control practice 
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 Critical care environment 
 Staffing pattern 
 Intubation precautions 
 Positive pressure ventilation 
 Pharmacological strategies 
 Prevention of aspiration 
 Prevention of contamination of equipments 
 Prevention of colonization of the aerodigestive tract 
 Implementation of VAP bundle 
 Surveillance of ventilator associated pneumonia 
NEED FOR THE STUDY 
Ventilator associated pneumonia is one of the leading cause of mortality and morbidity in 
critically ill patients. Proper implementation of the prevention protocol is essential in preventing 
VAP and thereby reducing the economical, personnel and material resources. So the investigator 
felt the definite need for subglottic suctioning, proper hand hygiene technique, and use of 
personal protective measures, proper positioning, staff education and developing a modified oral 
care protocol for intubated patients, in reducing the incidence of ventilator associated 
pneumonia.  
Microbial colonization of the oropharynx and dental plaque has been associated with 
systemic and respiratory disease, most notably ventilator associate pneumonia (VAP). VAP 
affects 8% to 28% of patients receiving mechanical ventilation, with mortality rates ranging from 
24% to 50%. Mortality rates may be as 7% for infection caused by high risk pathogens such as 
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pseudomonas or Acinetobacter. Prolonged ICU and hospital stays result in increased costs 
(Cutler et al. 2005).  
Meticulous mouth care is critical in prevention of VAP. The buccal cavity and dental 
plaque act as perfect media in which bacteria can colonize. 40% to 60% of endogenous lung 
infections are due to aspirated oropharyngeal secretions. 20% to 40% of these bacteria were 
staphylococcus aureus, and more than half of them are methicillin resistant (Porzecanski et al. 
2006). 
Grap et al. (2009) quoted that the bacteria reside in plaque and are transmitted to the 
lungs via micro aspiration. Dental plaque can be recognized only by tooth brushing. The study 
demonstrated the tooth brushing is an effective way to reduce the incidence of VAP as it 
removes the plaque that harbors bacteria. 
Aspiration is a potential hazard for the patient with an endotracheal tube. Oral intubation 
increases salivation and swallowing is difficult, causing pooling of secretion. So proper oral 
hygiene, frequent oral suctioning and subglottic aspiration is very essential to prevent oral 
colonization of microorganisms and their transduction to lung tissue. 
Nursing education regarding oral care practices for mechanically ventilated patients has 
comfort rather than a need to promote health. This contributes to the decreased attention, priority 
and frequency of plaque removal. Hence attention to the oral care of intubated patients using a 
modified oral care protocol is emphasized. 
The development of nosocomial pneumonia depends on the virulence of the bacterial 
species, the size of inoculation and the capacity of the pulmonary defense mechanism. With the 
suctioning of subglottic secretions, the volume of oropharyngeal suctions aspirated into the 
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bronchial tract and the size of inoculation are lowered. Thus continuous aspirations of subglottic 
secretions in intubated patients reduce VAP episodes. 
Manual intermittent aspiration of subglottic secretions shows a decrease in the incidence 
of ventilator associated pneumonia and a delay in the emergence of pneumonia during 
mechanical ventilation. Endotracheal tubes used are those with a subglottic suctioning port. 
Subglottic secretions were aspirated hourly. The intervention represents a simple, inexpensive, 
and useful approach in the prevention of nosocomial pneumonia (Mahul et al. 2006). 
Nurses in critical care unit are required to provide expertise care to patients on ventilator. 
As patients in critical care unit are confined to bed nurses have to assist or perform various 
activities of daily living of the patient, until he/she regains his/her independence. Beside 
ventilator complication of immobility like bed sores, deep vein thrombosis, hypostatic 
pneumonitis, etc. the nurses thus need to have adequate knowledge patience and empathy for 
patient’s conditions when he/she is on ventilator. An efficient nurse should also see that she/he 
acts as a liaison between the patients his/her relatives and the health care team members, in order 
to help the patients to progress towards recover. 
As the investigator had been working in the critical care units during his professional 
career he found that the nurses do carry out the management of patient on ventilator but not up to 
the required standard resulting in so many complications such as ventilator induced lung injury, 
ventilator associated pneumonia, respiratory distress syndrome, infection etc. The investigator 
felt that every nurse should rationalize his/her actions while managing a patient on ventilator.  
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STATEMENT OF THE PROBLEM 
A Study to evaluate the impact of comprehensive interventional package to identify the 
risk of ventilator associated pneumonia among ventilated patients in selected hospital, Madurai. 
OBJECTIVES 
Objectives of the study were to; 
1. To assess the risk of ventilator associated pneumonia before and after implementation of 
comprehensive interventional package among patients in control and experimental group. 
2. To determine the impact of comprehensive interventional package on ventilator 
associated pneumonia risk by comparing pre-test and post-test scores among control and 
experimental group. 
3. To determine the impact of comprehensive interventional package on ventilator 
associated pneumonia risk by comparing post-test scores between the control and 
experimental group. 
4. To find out the association between the risks of ventilator associated pneumonia among 
ventilated patients with their selected demographic and clinical variables in control and 
experimental group. 
HYPOTHESES 
1. There is a significant difference in the pre-test and post-test score among control and 
experimental group before and after implementation of comprehensive interventional 
package. 
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2. The mean post-test score of risk of ventilator associated pneumonia is significantly higher 
among the ventilated patients in experimental group than the ventilated patients in the 
control group. 
3. There is a statistically significant association between risk of ventilator associated 
pneumonia with selected demographic and clinical variables in both control and 
experimental group. 
OPERATIONAL DEFINITION 
Evaluate the impact 
In this study it refers to judge or determine the significance of comprehensive 
interventional package, and to a way of evaluating changes from comprehensive interventional 
package on identifying the risk of ventilator associated pneumonia. 
Comprehensive interventional package 
In this study it refers to the set of interventions used to identify the risk of ventilator 
associated pneumonia (oral hygiene, Endotracheal suctioning, semi-recumbent positioning, 
single use equipment, personnel protective measures, staff education and changing ventilator 
circuit).  
Ventilator associated pneumonia 
In this study it refers to the pneumonia that develops in intubated patients after 48 hours 
or more of mechanical ventilator support as assessed by the clinical pulmonary infection score. 
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Ventilated patients 
In this study it refers to those clients who have been intubated with Endotracheal tube for 
maintaining ventilation and stabilize respiratory parameters. 
Selected hospital 
In this study it refers to the Velammal Medical College Hospital and Vadamalayan 
Hospital which is being selected for doing the study and implementing the interventions on the 
selected patients. 
ASSUMPTION 
It is assumed that: 
 The comprehensive interventional package will reduce the incidence of ventilator 
associated pneumonia among ventilated patients. 
 The risk of ventilator associated pneumonia does not vary with their selected 
demographic variables. 
DELIMITATIONS 
 The study is delimited to the risk of ventilator associated pneumonia among ventilated 
patients in the selected hospital. 
 Patients already intubated (more than 12 hours). 
 Patients being intubated in other hospital and brought for further management. 
 The participants constitute a convenience sampling that may limit transferability of 
results to other population. 
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PROJECTED OUTCOME 
The findings of the study will help to: 
 Identify the impact of comprehensive interventional package. 
 Reduce the incidence of ventilator associated pneumonia. 
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CHAPTER II 
REVIEW OF LITERATURE 
This chapter deals with the information gathered from various research articles and 
unpublished thesis, related to the present study. Literature review helps the researcher to 
strengthen the present study by laying a better foundation and also to mould the study for best 
outcome. The review for the present study is categorized as follows: 
a) Reviews related to incidence of VAP 
b) Reviews related to the risk of VAP 
c) Reviews related to the prevention of VAP 
d) Reviews related to treatment modalities and care for intubated clients 
(a) Reviews related to incidence of VAP 
Samir Jaber et.al. (2012) conducted a prospective epidemiologic study to identify the 
risk of ventilator associated pneumonia. Totally 339 patients were selected with severe Acute 
Respiratory Distress Syndrome (ARDS). During the study period patients with suspected 
ventilator associated pneumonia underwent bronchoalveolar lavage to confirm the diagnosis. 
Findings revealed that 98 (28.9%) patients had at least one episode of microbiologically 
documented ventilator associated pneumonia, including 41 (41.8%) who died in the ICU, 
compared with 74 (30.7%) of the 241 patients without ventilator associated pneumonia (p=0.05), 
who received cisatracurium besylate therapy within 2 days of ARDS and decreased the risk of 
ICU death. Factors independently associated an increased risk to develop ventilator associated 
pneumonia were male sex and worse admission Glasgow Coma Scale (GCS). The other methods 
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Tracheostomy, enteral nutrition and the use of a supraglottic secretion-drainage device were 
protective in patients with severe ARDS. The results revealed that patients who received 
cisatracurium therapy and other methods were effective in reduction of ventilator associated 
pneumonia. 
Thomas Benet et.al. (2011) conducted a surveillance based study to identify the early 
onset of ventilator associated pneumonia incidence in ICU. The inclusive criteria were: first ICU 
admission, not hospitalized before admission, invasive mechanical ventilation during first ICU 
days, free of antibiotic at admission and ICU stay ≥ 48 hours. Totally, 367 (10.8%) of 3,387 
patients were developed ventilator associated pneumonia within first 9 days. The predicted 
cumulative ventilator associated pneumonia incidence was increased 23.0 (20.8-25.3) at D8. The 
proportion of missed ventilator associated pneumonia within 48 hours from admission was 11% 
(9%-17%). This study results shows the underestimation of early-onset ventilator associated 
pneumonia incidence in ICUs, if only ventilator associated pneumonia occurring ≥48 hours are 
considered to be hospital-acquired. So clinicians should be encouraged to develop a strategy for 
early detection of Ventilator associated pneumonia after ICU admission to reduce the ICU 
mortality. 
Palmore et al. (2010) conducted a surveillance based study to determine health care 
associated infections (HAI) are significant contributors to unnecessary morbidity associated with 
healthcare delivery in the United States, placing the field of healthcare epidemiology under 
intense scrutiny. The centers for Disease Control and Prevention (CDC) noted that 1.7 million 
HAI and nearly 99,000 deaths reported in U.S hospital in 2002, which exceed the number of 
deaths from any common disease. CDC epidemiologists estimated that 36.3% of these deaths 
were associated with pneumonia, mainly hospital acquired. The U.S Government Accountability 
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Office has kept HAI among the top 10 causes of death in the United States. The results revealed 
that Ventilator Associated Pneumonia (VAP) is a major clinical problem for critically ill and 
immune compromised patients since they require higher antibiotics, increased length of stay, and 
increased mortality. A substantial portion of patients who die while hospitalized in intensive care 
units die with complications, if not of, VAP. 
Javier Hortal et.al. (2009) conducted a prospective study to identify the ventilator 
associated pneumonia in patient’s undergone major cardiac surgery. Overall 25 hospitals in 8 
different European countries were participated in the study. Patient was selected based on the 
protocols. The number of patients intervened for major heart surgery was 986. One or more 
nosocomial infections were detected in 43 (4.4%) patients. Ventilator associated pneumonia was 
the most frequent nosocomial infection (2.1%; 13.9 episodes per 1000 days of mechanical 
ventilation). They identified the following significant independent risk factors for ventilator 
associated pneumonia: ascending aorta surgery [odds ratio (OR) = 6.22; 95% confidence interval 
(CI) = 1.69 to 22.89), number of blood units transfused (OR = 6.65; 95%, CI = 1.04 to 1.13) and 
need for reintervention (OR = 6.65; 95%, CI = 2.10 to 21.01)]. The median length of stay in the 
Intensive care unit was significantly longer (p<0.001) in patients with ventilator associated 
pneumonia than in patients without ventilator associated pneumonia (23 days versus 2 days). 
Patient’s undergone aortic surgery and those with complicated post-intervention, constitute a 
high-risk group probably requiring more active prevention measure. The results revealed that, 
increased hospital stay will increase the incidence of Ventilator associated pneumonia. 
Luis Camargo.F.A. et.al. (2004) conducted a prospective follow-up study to compare 
the effectiveness of quantitative and qualitative culture of tracheal aspiration for diagnosed 
ventilator associated pneumonia. Totally 106 intensive care patients were under ventilator 
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support. In total, the findings from 219 sequential weekly evaluations for ventilator associated 
pneumonia were examined. At the same time, cultures of tracheal aspirations were analyzed 
qualitatively and qualitatively 105 colony-forming units and 106 units. Results revealed that 
quantitative cultures of tracheal aspirations in selected critically ill patients had decreased 
sensitivity when compared with quantitative results, and they should not replace the latter to 
confirm a clinical diagnosis of ventilator associated pneumonia or to adjust antimicrobial 
therapy. 
(b) Reviews related to the risk of VAP 
Virginia Bonsal Cooper et.al. (2013) conducted a prospective study on incidence and 
risk factor for ventilator associated pneumonia in critically ill patients in Canada. Data was 
collected from 16 ICUs to determine the conditional probability and cumulative risk over the 
duration of stay in the ICUs. The sample was 1014 mechanically ventilated patients. The results 
showed that 177 (17.5%) patients developed higher risk for ventilator associated pneumonia, 
whereas 526 (51.87%) patients developed moderate risk for ventilator associated pneumonia and 
311 (30.67%) developed mild risk after the ICU admission. 
Christine Ilson et.al. (20010) conducted a study to assess the effectiveness of  selective 
oropharyngeal decontamination significantly reduces the rate of colonization and infection in 
patients receiving mechanical ventilation for more than 4 days to assess the risk of ventilator 
associated pneumonia. It suggested that chlorhexidine gluconate rinses for patients in 
experimental group might be beneficial in reducing bacteria in dental plaque, which may be a 
source of pathogens for development of ventilator associated pneumonia. The study reveals that 
out of 50 patients 29(58%) had no risk, whereas 15 (30%) patients developed some risks and 6 
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(12%) developed high risk for ventilator associated pneumonia. Topically applied antibiotics, or 
chlorhexidine gluconate rinses may aid in reducing bacteria in mouth, potentially decreasing the 
risk for ventilator associated pneumonia. 
Braine B. Fields et.al. (2009) conducted a prospective study to assess impact of 
adherence to a ventilator associated pneumonia bundle on the risk of VAP in surgical intensive 
care unit of Boston Medical Centre in Boston over a 38 month period. A daily checklist was 
considered complaint if all the items were performed for all patients. Prior to initiation of bundle 
of VAP was seen at a rate of 10.2 cases per 1000 ventilator days. Compliance with bundle 
increases over the study period from 53% and 63% to 91% and 81% in each respective SICU. 
Results revealed that the risk of VAP decreased to 3.4 cases per 1000 ventilator days among 
clients in interventional group. 
Di Chamberlain et.al. (2008) conducted a prospective observational study for one year 
in the PICU of postgraduate Institute of Medical Education and Research, Chandigarh, to 
determine the incidence, aetilology and risk factor of ventilator associated pneumonia (VAP). 
Patients who needed ventilator support, were included and diagnosis of nosocomial was made 
with regard to CDC guideline. Out of the total 30.5% risk for ventilator associated pneumonia. 
The study results were concluded that mechanical ventilation was the significant risk factor for 
development of ventilator associated pneumonia. On multiple regressions analysis re-intubation 
was the single risk factor for VAP. Overall mortality rate was 21%, and 7% of these deaths were 
due to ventilator associated pneumonia. 
Santiago C et.al. (2002) conducted an experimental study to determine the incidence and 
risk of ventilator associated pneumonia in trauma ICU. Pressures in the cuffs of the endotracheal 
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tubes were measured at time of specimen collection and were compared with pressures recorded 
approximately 6 to 7 hours earlier. A total of 41 observations were made. In 30 instances (73%), 
the cuff pressure was less than that recorded in the morning. Mean cuff pressure were 21 cm H2O 
in the morning and 17 cm H2O in the afternoon. This difference was significant (paired t test, 
p<0.01). In 8 observation (20%), the pressure were 10 12 cm H2O less than the morning 
pressure. These findings are clinically important, because in one study, maintaining the cuff 
pressure at 20 cmH2O or higher reduced the risk of VAP. The study findings revealed that 
maintenance of optimum pressure in cuffs of endotracheal tube reduces the incidence and risk of 
developing ventilator associated pneumonia. 
Shobha Gaikward et.al. (2000) conducted a prospective observational study in NICU of 
CSM Medical University, Lucknow (UP) to assess aetilology and risk factors of VAP in 
neonates over a period of one year. Neonates admitted in NICU who required mechanical 
ventilation for more than 48 hours were enrolled in to the study the study group comprised of 98 
neonates out of which,  30 neonates developed VAP (30.6%). VAP rates were 37.2 per 1000 
days of mechanical ventilation. Most common bacterial organisms isolated from endotracheal 
aspirate of VAP patients were Klebsiella spp (32.8%), E coli (23.2%), and Acinobacter (17.8%). 
Multiple regression analysis revealed that duration of mechanical ventilation (OR 1.10, 95% CI 
1.02, 1:21; P=0.021) and very low birth weight (OR 3.88, 95% CI 1.05, 14.34; P=0.042) were 
two statistically significant risk factors in predicting VAP. Results revealed that very low birth, 
prematurity, duration of mechanical ventilation, number of reintubations, and length of ICU stay 
were significantly associated with VAP in bivariate analysis. 
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(c) Reviews related to the prevention of VAP 
Schultz et.al. (2010) conducted an experimental study to determine the impact of 
establishment of an artificial airway on the risk of contamination of the respiratory tract of 
critically ill and often immunocompromised intensive care unit patients. Subsequent colonization 
may lead to ventilator associated pneumonia, a feared and common complication in the ICU 
setting. Prevention of VAP is extremely important because of its worsening consequences. 
Preventive measures include but not restricted to, early Weaning, Hand hygiene, Aspiration 
precautions, and Prevention of contamination (WHAP). The results findings reveled that an 
educational initiative on WHAP, directed at respiratory care practitioners and intensive unit 
nurses, was associated with decreases in VAP incidence rates of up to 61%. 
Gentile et.al. (2010) conducted a prospective study to determine that prevention of VAP 
is a multifaceted priority of the intensive care team. Introduction of specialized artificial airway 
is a milestone in evolving technologies in preventing VAP. The study results suggests that the 
use of endotracheal tube with a dorsal subglottic lumen, silver – coated and antiseptic – 
impregnated Endotracheal tubes reduces the incidence of VAP by 50%. 
Omrane et.al. (2007) conducted a surveillance study to assess the impact of a protocol 
incorporated with evidence based interventions, in reducing the frequency and overall rate of 
VAP. A pre and post intervention observational study was conducted. Mechanically ventilated 
patients in Montreal General Hospital for duration of one year were included. A 
multidisciplinary prevention protocol was developed and implemented for all patients. Rate of 
VAP per 1000 ventilator days were calculated before and after the implementation of the 
multidisciplinary prevention protocol. Results showed 23 VAP episodes in 925 ventilator-days 
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during post intervention period (p=0.001). Implementing a VAP prevention protocol 
incorporated with evidence based guidelines reduced the crude incidence of VAP including early 
and late onset VAP. 
Blot et.al. (2007) conducted an experimental study to assess the knowledge of intensive 
care unit nurses on evidence based guidelines for the prevention of VAP using a validated 
multiple choice questionnaire. Among 638 respondents 19% recognized oral intubation as the 
recommended way for intubation; 49% suggested changing the ventilator circuit for each new 
patient; 60% respondents recognized subglottic drainage is known to prevent VAP by 90%. The 
results revealed that, as a whole nurses lack knowledge regarding recommendation for VAP 
prevention. 
Safdar.et.al. (2005) conducted a prospective study to identify the strategies to prevent 
risk of VAP among mechanically ventilated patients. The strategies to prevent VAP could be 
better developed only if a sound understanding of pathogenesis and epidemiology exists. The 
major route for acquiring VAP seemed to be the endogenous flora or by pathogens acquired 
exogenously from ICU environment (hands or apparel of health team members, contaminated 
respiratory equipment, hospital water, or air). Apart from that stomach represents a potential site 
of secondary colonization and reservoir of nosocomial Gram-negative bacilli. Biofilm formation 
in Endotracheal tube contributes to tracheal colonization and lead to late-onset VAP, after seven 
days of intubation. VAP results from aspiration of oropharyngeal, gastric and tracheal secretions 
around cuffed Endotracheal tubes into the sterile respiratory tract. The study result findings 
conclude that strategies to prevent risk of VAP include oral care, prophylactic aerosolization of 
antimicrobials, selective aerodigestive mucosal antimicrobial decontamination, stress ulcer 
prophylaxis and measures to prevent aspiration (VAP bundle with subglottic suctioning). 
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Epidemic VAP incidence could be zeroed if rigorous disinfection of respiratory equipments and 
bronchoscopes, and infection control measures were followed strictly. 
(d) Reviews related to treatment modalities and care for intubated patients 
Speroni.K.G. et.al. (2011) conducted an experimental study to evaluate the effectiveness 
of continuous aspiration of supraglottic secretion on the prevention of ventilator associated 
pneumonia in mechanically ventilated patients. Patients with mechanical ventilator were 
randomly divided into two groups. Continuous aspiration of supraglottic suctioning was 
performed to experimental group immediately after endotracheal intubation. Results shows, that 
continuous supraglottic suctioning was effective in reduction of ventilator associated pneumonia. 
Garcia et.al. (2009) conducted a quasi experimental study to determine the effect of a 
comprehensive oral and dental care protocol on the rate of VAP by pre-post interventional study. 
Adults receiving mechanical ventilation more than 48 hours in Brookdale University Hospital 
were studied in a two consecutive 24 month periods. Pre-interventional group (n=779) had no 
oral assessments, no subglottic suctioning, no tooth brushing, and suctioning of secretions in oral 
cavity as needed. The interventional group (n=759) was treated with a protocol which included 
oral assessment, deep suctioning every 6 hours, oral tissue cleaning every 4 hours or as needed 
and tooth brushing twice daily. VAP rate was determined using clinical pulmonary infection 
score (CPIS) (CPIS>6). The rate of VAP was found to be 12% per 1000 ventilator days before 
the intervention and decreased to 8.0% per 1000 ventilator days during the intervention 
(p=0.006). Research study results concluded that the implementation of comprehensive oral care 
protocol and staff compliance significantly reduced the VAP rate and its associated costs. 
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Grap.et.al. (2009) conducted a survey on oral care interventions in critical care. Patient’s 
oral care is a component of nursing care. Oral care is often considered primarily an intervention 
for patient’s comfort which may reduce its priority and frequently. Oropharyngeal colonization is 
associated with several systemic diseases, including cardiovascular disease, chronic obstructive 
pulmonary disease, and in ICU Ventilator Associated Pneumonia (VAP). VAP occurs in 9% to 
24% of patients with various pulmonary disorders. The mortality rate of VAP varies from 54% 
and 71% and mortality is particularly high in pneumonia attributed to pseudomonas or 
Acinetobacter. Dental plaque colonized with microbes serve as a reservoir for pathogens in 
patients with poor oral hygiene. Tooth brushing is effective in reducing number of oral microbes, 
but it is not routinely performed in ICUs. The lack of published oral care interventions reported 
by nurses and showed how often these interventions were documented in medical records. The 
subjects surveyed include 170 nursing care providers and all critically ill patients above 18 years 
for a period of one month. 75% of respondents reported providing oral care 2 to 3 times per day 
for none intubated and 72% reported providing oral care more than 5 times per day for intubated 
patients. Result findings revealed that reported use of toothbrush (p<001) for non intubated 
patients was significantly greater than intubated patients. ICU nurses might be hesitated to 
provide oral care to intubated patients because ET tubes may limit access to the oral cavity and 
the fear of tube displacement. These problems can be solved by using a pediatric toothbrush with 
soft bristles. 
Hutchins et.al. (2009) conducted a quality improvement project in Critical Care Unit of 
spring field medical center based on the findings that VAP develops at a rate of 1% to 3% per 
day of mechanical ventilation. Mechanically ventilated patients intubated in the study received 
the modified oral care protocol every 4 hours, tooth brushing with povidine iodine solution using 
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a suction toothbrush, cleaning oral cavity with hydrogen peroxide swabs, application of a 
moisturizer and deep oropharyngeal suctioning. The primary efficiency variable, VAP was 
reduced to 4.12 in December 2005 to 3.57 for 2006 and to 1.3 for 2007, after the inception of the 
quality improvement project. The study results conclude that the introduction of a modified oral 
care protocol with ventilator bundle led to 89.7% reduction in VAP rate from 2004 to 2007. 
Munro.et.al. (2009) conducted a study to evaluate the effects of mechanical (tooth 
brushing), pharmacological (topical chlorhexidine), and combination oral care (tooth brushing 
plus chlorhexidine) in reducing the VAP rate using randomized controlled clinical trial with a 
2x2 factorial designs. He enrolled 249 intubated patients within 24 hours of intubation from there 
ICUs. Patients with clinical diagnosis of pneumonia at the time admission were excluded. 
Patients were randomized to one of the four treatment group, 0.12% chlorhexidine swab twice 
daily, tooth brushing thrice daily, both tooth brushing and chlorhexidine, and usual care. Dates 
were collected using Clinical Pulmonary Infection Score (CPIS). Results proved that 
chlorhexidine in combination with tooth brushing significantly reduced the incidence of VAP 
(CPIS<6) by day 3. 
Sona.et.al. (2009) conducted a pre-post intervention observational study to determine the 
effect of a simple low-cost oral care protocol on VAP rate, in 24 bedded surgical ICU of Barnes 
Jewish Hospital, Mission. All mechanically ventilated patients for a time period of one year were 
enrolled in the study. The oral care protocol involved tooth brushing and subsequent application 
0.12% chlorhexidine gluconate twice daily in 12 hours interval. During pre-intervention period 
there was 24 infections in 4606 ventilated days (rate=5.2 infections per 1000 ventilator days). 
There was a reduction in the incidence of infection to 10 in 4158 ventilator days resulting in a 
lower rate of 2.4 per 1000 ventilator days. There was a statistical significance in this 46% 
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reduction of VAP (p=0.04). The fewer cases of VAP led to decrease in cost of US $ 1, 40,000 to 
US $ 5, 60,000 based on estimated cost of VAP. Study result revealed that there was an overall 
reduction of VAP rate by implementation of a low-cost oral care protocol. 
Arabia.Y et.al. (2008) conducted a randomized control trial study to evaluate the rate of 
ventilation associated pneumonia by using the National Healthcare Safety Network (NHSN). The 
rates of ventilator associated pneumonia varied from 10 to 41.7% and were gradually higher than 
NHSM rates. Gram negative bacilli were the most common pathogens, implementation of hand 
hygiene and ventilation associated pneumonia prevention was practiced to reduced ventilator 
associated pneumonia. The results revealed that ventilator associated pneumonia was reduced 
from 94 to 16% after educational program. 
Fields.et.al. (2008) conducted an experimental study to assess the effectiveness of VAP 
bundle on preventing the incidence and risk of VAP. The mechanically ventilated patients in 
neurologic and other intensive care units are at increased risk of VAP due to decreased level of 
consciousness, dry open mouth, and micro aspiration of secretions. VAP can be prevented by 
initiating interventions from the institute of healthcare improvement’s (IHI). VAP bundle 
included, elevating the head end of the bed to 300, DVT prophylaxis, gastric ulcer prophylaxis, 
early mobilization and sedation. The one intervention not included in IHI bundle is oral hygiene. 
This project aimed at timed tooth brushing combined with VAP bundle in minimizing and 
preventing the occurrence of VAP. A randomized controlled trial was initiated on a 24-bed ICU 
with sterile precautions. Nurses were instructed about the importance of oral care and how to do 
it using a toothbrush with soft bristle. The protocol included using a toothpaste, application of 
moisturizing agent every 4 hours, oral and pharyngeal suctioning with an enclosed suction 
catheter, which was disposal of every 24 hours, and inspection of oral cavity every 24 hours. The 
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results concluded, as the VAP rate dropped to zero within a week of beginning the every 8-hours 
tooth brushing regimen in the intervention group. The study was too successful that the control 
group was dropped after 6 months, and all intubated patients were brushed every 8 hours. 
Tsai.el.al. (2008) conducted a prospective evaluation of usefulness of intermittent 
suctioning of oral secretions before each position change in reducing VAP. A time sequence non 
randomized intervention design was used. After a duration of 9 month observation phase and 6 
month education phase, followed by a 7 month intervention phase the occurrence of VAP rate 
was reduced in studied group (6 of 227 patients, 2.6%) than control group (26 of 237 patients, 
11%) (p<0.001). The incidence of VAP in control and study group was 6.51 and 2.04 per 1000 
ventilated days respectively (p=0.002). The results revealed that intermittent suction of oral 
secretion before each position change proved to be effective in reducing VAP. 
Berry.et.al. (2007) conducted a prospective study to determine the impact of proposed 
oral hygiene as a key intervention for reducing ventilator associated pneumonia. In his study 
Berry recognized oral hygiene in combination with subglottic suctioning reduces the incidence of 
VAP from 28% to 9%. The use of a flexible suction catheter during oropharyngeal suctioning 
reduces the incidence of aspiration. Results revealed that oral hygiene in combination with 
subglottic suctioning reduced the incidence of VAP. 
Lacherade.et.al. (2010) conducted a study to determine the effect of subglottic secretion 
drainage (SSD) in reducing the incidence of microbiologically confirmed VAP. Patients of four 
French hospital ICUs, were enrolled in a randomized clinical trial. Among 333 patients 169 were 
assigned to experimental group, receiving intermittent SSD and 164 in control group not 
receiving SSD. Occurrence of VAP, using distal pulmonary sampling confirmed VAP in 67 
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patients, 25 (14.8%) of interventional and 42 (25.6%) of control group (p=0.02). The relative risk 
reduction was 42.2%.  Results finding revealed that, statistically the incidence of both early 
(1.2%) in interventional and 6.2% in control group (p=0.02), as well as onset VAP (18.6% in 
interventional and 33.0% in control group [p=0.01]) were reduced by eliminating SSD. The 
influence of SSD is reducing VAP had been proved. 
Bonza.et.al. (2008) conducted a study that compared conventional and continous 
aspiration of subglottic secretion (CASS) procedure in reducing VAP. A population of 714 
patients was randomized as 331 in control group and 359 in CASS group. In mechanically 
ventilated patients >48 hours the VAP incidence was 26.7% in CASS group and 47.5% in 
control group (p=0.04); incidence density, 31.5 Vs 51.6 episodes per 1000 days of mechanical 
ventilation respectively (p=0.03) median length of ICU stay, 7 Vs 16.5 days (p=0.01) 
respectively. The study results was concluded as CASS is a safe procedure that reduces the use 
of antibiotics and incidence of VAP in at risk patients and no complications related to CASS 
were observed. 
Depew.et.al. (2007) conducted a surveillance study to assess the effectiveness of 
endotracheal tube with an aspiration port reduces the incidence and risk of VAP. VAP is a costly 
complication of hospitalization that lengthens ICU stay, increasing morbidity and mortality. Use 
of a specialized endotracheal tube with an aspiration port that aspiration subglottic secretion 
reduces the micro aspiration of colonized secretions into lower airways. Recommendations for 
VAP prevention by the centers for Disease Control and Prevention, complication during 
subglottic secretion drainage, and major issues in implementing the use of an endotracheal tube 
with subglottic port need to be documented. The results revealed that use of a specialized 
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endotracheal tube with an aspiration port that aspiration subglottic secretion reduces the 
incidence and risk of VAP. 
Neal.O.et.al. (2007) conducted a prospective study to identify the risk of VAP. 
Aspiration of subglottic secretions plays a major role in the development of VAP with a 
mortality rate up to 71%. The focus of this study was to find out the optimal suction pressure 
levels needed to efficiently evacuate subglottic secretions. The effectiveness of suction pressures 
(20 mm of Hg, 30 mm of Hg, 40 mm of Hg and 50 mm of Hg) needed to maximize evacuation 
efficiency based on volume and viscosity of subglottic secretions (2ml, 4ml and 6ml) was 
studied. The result showed that thick secretions had the highest percentage of secretion recovery 
(83%). Thus study demonstrated that highly viscous secretions are easier to evacuate when the 
suction pressure applied was 30 mmHg. Removal of subglottic secretion irrespective of its 
viscosity and amount assist in delaying the development of VAP. 
Snodders.et.al. (2002) conducted a study to determine the effect of subglottic secretion 
drainage on the incidence of VAP in mechanically ventilated patients. A randomized clinical trial 
was used in a 12 bedded general ICU. 150 patients receiving mechanical ventilation >72 hours 
were randomized equally to experimental and control group. Homogeneity was minimized in 
both groups with respect to demographic characteristics and severity of illness. Experimental 
group were intubated with an Endotracheal tube with intermittent subglottic drainage port and 
control group were intubated with a standard Endotracheal tube. The outcome variables 
measured by the researcher were the incidence of VAP, duration of mechanical ventilation, 
length of ICU and hospital stay and mortality. Using clinical pulmonary infection score (CPIS). 
VAP rate was diagnosed to be 4% in experimental group and 16% in control group (p=0.014) 
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and other outcome were not significant. Results concluded that intermittent subglottic drainage 
was effective in reducing VAP incidence in mechanically ventilated patients. 
Shorr et.al. (2001) conducted an experimental study to determine the cost effectiveness 
of continuous subglottic suctioning (CSS) as a strategy to decrease the incidence of VAP. 
Decision model analysis of the cost and efficiency of CSS Endotracheal tubes in preventing VAP 
was used. Estimated models were based on the data from published prospective trails of CSS 
prospective studies of VAP. Hypothetical cohort of 100 patients requiring nonelective intubation 
in ICU was the inclusion criteria. The calculated marginal cost effectiveness of CSS was the 
saving from cases of VAP averted minus additional cost of CSS-ETs, and expressed as cost per 
episodes of VAP prevented. Despite higher cost of CSS-ETs, a net savings of $4,992 was 
achieved resulting in $1,924 savings per case of VAP prevented. Research study results revealed 
that CSS continued to be a better cost effective strategy for VAP prevention. 
Kollef et.al. (1999) conducted a randomized clinical trial of continuous aspiration of 
subglottic secretion (CASS) in 343 cardiac surgery patients in cardiothoracic ICU of Barnes 
Jewish Hospital, St. Louis. Patients were randomized to receive either CASS or routine 
postoperative medical care without CASS. Homogeneity maintained in case of demographic 
characteristics, surgery performed and severity of illness. Results showed the occurrence of VAP 
was less in experimental group as compared to control group. 
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CONCEPTUAL FRAMEWORK 
The conceptual framework selected for the study was based on Ernestine Wiesenbach’s 
“Prescriptive theory – 1969”. 
Conceptual framework serves as a spring board for theory development. The conceptual 
framework for the research study presents the measurement on which the purpose of the 
proposed study is based. The framework provides the prospective from which the investigator 
views the problem. The study is designed to assess the effectiveness of comprehensive 
interventional package on prevention of risk of ventilator associated pneumonia among 
ventilated patients. 
The study is based on the concept that implementation of comprehensive interventional 
package aids in the prevention of risk of ventilator associated pneumonia. The investigator 
adopted the Wiesenbach’s theory of helping art of clinical nursing 1969 for conceptual 
framework. 
Wiesenbach’s prescriptive theory directs action toward an explicit goal. It consists of 
three factors identification, prescription and realities. A critical care nurse develops a 
prescription based on identification and implements it according to the realities of the situation. 
Ernestine Wiesenbach proposed prescriptive theory for nursing, which is described as conceiving 
of desired situation and the way to attain it. 
According to this theory nursing practice consists of three steps, which include 
Step 1: Identifying the need for help. 
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Step 2: Ministering the needed help. 
Step 3: Validating that the need for help was met. 
Identifying the need for help 
Nurses in patients care tends to find out the needs and problems of the patients and helps 
them to solve for the better outcome and health improvement. In this study the mechanically 
ventilated patients needs complete care to aid in better health outcome and prevent 
complications. The investigator identified that Comprehensive interventional package will be 
effective in preventing the risk of ventilator associated pneumonia among the mechanically 
ventilated patients. 
Ministering the needed help 
For a problem to be solved an intervention has to be given and the needs must be met to 
by the patient. Ministering care refers to providing needed care or help for the clients. In this 
study comprehensive interventional package (oral hygiene, Endotracheal suctioning, semi-
recumbent positioning, single use equipment, personnel protective measures, staff education and 
changing ventilator circuit) was ministered to the mechanically ventilated patients to prevent the 
risk of ventilator associated pneumonia. 
Validating that the need for help was met 
Validating refers to establishing a soundness, accuracy or legitimacy of the achievement 
of desired or planed interventional outcome. In this study the investigator evaluated the impact of 
comprehensive interventional package by using modified clinical pulmonary infection score for 
preventing the risk of ventilator associated pneumonia. Implementation of comprehensive 
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interventional package will be effective in preventing the risk of ventilator associated pneumonia 
among the ventilated patients being exposed to the care. 
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FIGURE: 2.1. CONCEPTUAL FRAMEWORK BASED ON ERNESTEINE WEIDENBACH’S PRESCRIPTIVE THEORY (1969) 
IDENTIFICATION MINISTERING VALIDATION
I. Demographic 
variables 
II. Clinical variables 
III. Modified clinical 
pulmonary 
infection score. 
EXPERIMENTAL GROUP: 
 Comprehensive 
interventional package Control group Experimental 
group 
POST-TEST 
PRE-TEST 
No risk 
Mild risk 
Moderate risk 
High risk 
RISK OF 
VAP 
Experimental 
group 
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Followed in study 
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CHAPTER III 
MATERIALS AND METHODS 
It includes the research approach, research design, setting of the study, population, 
sample and sample size, method of sampling, criteria for sample selection, development and 
description of the tool validity and reliability of tool, procedure for data collection and plan for 
analysis, pilot study and ethical consideration. 
SCHEMATIC PRESENTATION OF RESEARCH 
  
 
 
 
 
 
 
 
 
 
 
 
Sample Technique‐ convenience sampling
Research design‐Quasi experimental design
Setting of the study‐ Selected hospital at Madurai
Sample‐ Ventilated patients
Sample size‐60 patients who were mechanically ventilated
Experimental group‐30 Control group‐30 
Pre‐test on risk factors of ventilator 
associated pneumonia 
Pre‐test on risk factors of ventilator 
associated pneumonia 
No intervention  Comprehensive interventional 
package 
Data analysisPost‐test Post‐test 
Findings and conclusion
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RESEARCH APPROACH 
In order to accomplish the objectives of this study, quantitative approach was adopted to 
evaluate the impact of comprehensive interventional package to identify the risk of ventilator 
associated pneumonia among ventilated patients. 
RESEARCH DESIGN 
In this study, quasi experimental pre-test post-test control group design was adopted to 
evaluate the impact of comprehensive interventional package to identify the risk of ventilator 
associated pneumonia among ventilated patients. It is assessed by the notations as: 
Experimental group O1 X O2 
Control group O1 - O2 
 
O1 – Risk of ventilator associated pneumonia before providing comprehensive 
interventional package 
O2 – Risk of ventilator associated pneumonia after providing comprehensive 
interventional package 
 X   –  Intervention (comprehensive interventional package) 
VARIABLES 
The present study has the following variables 
 Independent variable- comprehensive interventional package 
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 Dependent variable – ventilator associated pneumonia 
SETTINGS OF THE STUDY 
The researcher has chosen two hospitals which include Vadamalayan hospital and 
Velammal medical college hospital from Madurai, Tamil Nadu as experimental group and 
control group respectively for the present study. 
Vadamalayan multispecialty hospital, Madurai was selected as the experimental group 
for the study, which is 13 kilometer from C.S.I Jeyaraj Annapackiam College of Nursing, 
Pasumalai, Madurai, Tamil Nadu state, South India. It is 300 bedded multispecialty hospital and 
has health facilities such as casuality, cardio thoracic surgical intensive care unit (CTS-ICU), 
cardio thoracic operation theatre (OT), medical and surgical wards, post-operative units and 
maternity unit. 
Velammal Medical College Hospital, Madurai was selected as the control group for the 
present study, which is 15 kilometer from C.S.I Jeyaraj Annapackiam College of Nursing, 
Pasumalai, Madurai, Tamil Nadu state, South India. It is 1000 bedded medical college hospital 
and has health facilities such as casualty, cardio thoracic surgical intensive care unit (CTS-ICU), 
cardio thoracic operation theatre (OT), medical and surgical wards, post-operative unit and 
maternity unit, pediatric ward and ICUs and psychiatric ward.  
POPULATION 
 Target population - All the ventilated patients in all the hospitals in Madurai district. 
 Accessible population - Ventilated patients from selected hospitals in Madurai district. 
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SAMPLE 
The samples were the ventilated patients who fulfill the inclusion criteria. 
SAMPLE SIZE 
The sample comprised of 60 ventilated patients at selected hospitals in Madurai, among 
which 30 patients were assigned in the control group and 30 patients were in the experimental 
group. 
SAMPLING TECHNIQUE 
In the study, convenience sampling technique was used to select the sample. Samples 
were selected based on sampling criteria. 
CRITERIA FOR SAMPLE SELECTION 
Inclusion criteria 
Patients who were: 
 Under mechanical ventilator support 
 Patients of both genders 
 On first day of mechanical ventilation 
Exclusion criteria 
Patients who were: 
 Non-ventilated patients 
 Patients on mechanical ventilator more than 2 days 
 Being ventilated from outside hospitals or centers 
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DESCRIPTION OF THE TOOL 
The tool was developed by the investigator with the guidance of the expert’s opinion, 
various resources and review of literature. The tool used for the present study is risk assessment 
tool for VAP to identify the risk of ventilator associated pneumonia among ventilated patients. 
The tool comprised of 2 sections: 
 Section A - It includes 2 parts 
 Demographic variables 
 Clinical variables 
 Section B- Risk assessment tool for VAP 
SECTION - A 
Part - 1 
 In this study, demographic variables include age, gender, educational status, occupation, 
income, marital status. The researcher himself selected the appropriated answers based on 
client’s medical record. 
Part - 2 
 In this study, the clinical variables consisted of personal habits, past history of infection, 
Glasgow coma scale reading, use of relaxant and sedation, group of antibiotics, administration of 
prophylactic drug for peptic ulcer, diagnosis, reason for intubation and type and intubation. 
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SECTION - B 
It consists of 10 parameters related to risk of ventilator associated pneumonia, which 
includes the normal findings and the deviated findings. 
SCORING PROCEDURE 
SECTION - B 
Risk assessment tool for VAP consists of 10 parameters with the normal findings and the 
deviated findings. The normal finding was rated ‘0’ score and the deviated findings were scored 
‘1’. The score was ranged as follows 
Score Classification  
0 No infection 
1-3 Mild infection 
4-8 Moderate infection 
9-10 Severe infection 
VALIDITY AND RELIABILITY OF THE TOOL 
Validity 
The present study was validated by 11 nursing and 2 medical experts. They validated the 
entire section of the tool and evaluated the tool for its clarity, appropriateness, adequacy, 
relevance and completeness. Few modification and suggestion were made as per the 
recommendations made by the experts. The tool was refined and finalized after establishing the 
validity. 
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Reliability  
 The reliability of the tool was elicited by test re-test method using Karl Pearson’s 
correlation coefficient for knowledge was “r”=0.98, which was found to be reliable 
(Metheney et al. 2010). 
 The risk assessment tool for VAP had a sensitivity of 93%, a specificity and positive 
predictive value of 100% (Davis 2006). 
 After the pilot study the tool was found to be reliable and accepted for the study. 
PILOT STUDY 
The researcher conducted the pilot study in Velammal medical college hospital in 
Madurai. After obtaining administrative approval from the authorities concerned, the researcher 
selected 6 patients who were mechanically ventilated. Oral consent was obtained from the ICU 
in-charge. Out of 6 samples, 3 samples in experimental group and the other 3 samples in control 
group were selected for the study. Pre-test was carried out for both groups to identify the risk of 
ventilator associated pneumonia. On the same day after pre-test, samples in experimental group 
were provided with comprehensive interventional package interventions. Post-test was carried on 
the 3rd and 5th day by using the same tool. The mean post-test score was higher than the mean 
pre-test score in experimental group, which confirmed that the conduction of the main study 
would feasible. It also provided information regarding reliability, feasibility and practicability of 
the designed methodology. 
METHOD OF DATA COLLECTION 
The data was collected among mechanically ventilated patients in Vadamalayan 
multispecialty Hospital, Madurai and Velammal medical college Hospital, Madurai. The period 
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of data collection was 10 weeks, 60 patients were selected as per above mentioned criteria. Data 
was collected through relevant demographic variables, clinical variables and modified 
pulmonary infection score to identify the risk of ventilator associated pneumonia among 
ventilated patients. The data collection schedule was as follows: 
Group Period Setting Task 
Experimental  
10 weeks 
Vadamalayan 
Multispecialty 
hospital 
Day 1 
 Step 1 – orientation to staff 
 Step 2 – pre-test (0 or 1 day of 
ventilation) 
 Step 3 – implementation of 
comprehensive interventional 
package 
Day 3 
 Step 4 – post-test- I (3rd 
ventilator day) 
Day 5 
 Step 5 – Post-test- II (5th 
ventilator day) 
Control  Velammal Medical 
College Hospital 
Day 1 
 Step 1 – orientation to staff 
 Step 2 – pre-test (0 or 1 day of 
ventilation) 
Day 3 
 Step 3 – post-test- I (3rd 
ventilator day) 
Day 5 
 Step 4 – Post-test- II (5th 
ventilator day) 
 
STEPS OF DATA COLLECTION PROCESS 
Step 1 
 Self introduction to staff members in ICU, recovery units, Emergency. 
 Explanation about the purpose of the study to the staff in ICU, recovery unit, Emergency. 
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Step 2 
 Selection of samples and allotment to experimental group and control group based on the 
inclusion criteria. 
 Pre-test for both experimental and control group clients using modified pulmonary 
infection score. 
Step 3 
 Implementation of Comprehensive interventional package (oral hygiene, Endotracheal 
suctioning, semi-recumbent positioning, single use equipment, personnel protective 
measures, staff education and changing ventilator circuit) for prevention of ventilator 
associated pneumonia to the patients in the experimental group. 
 Routine interventions (endotracheal suctioning, positioning and oral hygiene) to the 
patients in control group. 
Step 4 
 Post-test was conducted for both the experimental and control group using the same tool 
on 3rd and 5th day. 
 After the data collection procedure, comprehensive interventional package for prevention 
of ventilator associated pneumonia was provided to the control group for ethical 
consideration. 
 A hearty gratitude was conveyed to the staff members for their co-operation and 
participation. 
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PLAN FOR DATA ANALYSIS 
Data analysis helps the researcher to organize, summarize, evaluate, interpret and 
communicate the numerical facts. For the present study the collected data from the participants 
were grouped and analyzed using both descriptive and inferential statistical methods. SPSS 16.0 
version was used for data analyses. 
Study plan to carry out the following analysis: 
 Gather all information’s obtained from the study tool 
 Enter the score in the spreadsheet 
 Coding the data 
Descriptive statistics 
Demographic variables and clinical variables were analyzed using frequency distribution 
and percentage analysis. 
Inferential statistics 
 Pre and post-test scores within group was analyzed by using paired “t” test. 
 Post-test scores between the groups were analyzed using independent “t” test. 
 Association between demographic variables and pre-test score was analyzed using chi-
square test. 
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ETHICAL CONSIDERATION 
The right to freedom from harm 
 Though this study is an experimental design, the interventions used were not of harm to 
the patients. 
The right to protection from exploitation 
 Patient’s information’s were kept undercover. 
The right to self-determination 
 Research proposal was approved by specialty HOD and other senior professors. 
 Prior permission was sought from higher authorities of institution before commencing the 
study. 
 Before consent is sought the researcher has given details of the nature and purpose of the 
research and proposal outcome of the research. 
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CHAPTER IV 
DATA ANALYSIS AND INTERPRETATION 
This chapter deals with the data analysis collected among mechanically ventilated 
patients and interpretation of the present study involves compilation, editing, coding, 
classification and presentation of the data for statistical calculation in order to draw inferences 
and conclusions.  Using descriptive and inferential statistics, the study objectives were 
computed. 
Objectives 
The data collected from the respondents were organized, tabulated, analyzed and includes 
applying descriptive and inferential statistics based on the objectives: 
1. To assess the risk of ventilator associated pneumonia before and after implementation of 
comprehensive interventional package among patients in control and experimental group. 
2. To determine the impact of comprehensive interventional package on ventilator 
associated pneumonia risk by comparing pre-test and post-test scores among control and 
experimental group. 
3. To determine the impact of comprehensive interventional package on ventilator 
associated pneumonia risk by comparing post-test scores between the control and 
experimental group. 
4. To find out the association between the risks of ventilator associated pneumonia among 
ventilated patients with their selected demographic and clinical variables in control and 
experimental group. 
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The findings were presented in the form of tables and diagrams under the following series: 
Section- A. This section shows the description of the socio demographical and clinical 
variables 
1. Frequency and percentage distribution of ventilated patients based on their socio-
demographic variables. 
2. Frequency and percentage distribution of ventilated patients based on their clinical 
variables. 
3. Distribution of ventilated patients based on their pulmonary infection score in the 
experimental and control groups. 
Section- B. Comparison of difference on risk of VAP among ventilated patients in the 
control and experimental groups 
1. Mean score difference on risk of VAP among ventilated patients in control and 
experimental groups. 
2. Paired’ test on risk of VAP among ventilated patients within the control and experimental 
groups. 
3. Independent‘t’ test for comparison of difference on risk of VAP among ventilated 
patients between the control and experimental groups. 
Section- C. Association of risk of VAP with selected socio demographic and clinical 
variables. 
1. Association of risk of VAP among ventilated patients in experimental group with their 
selected demographic variables. 
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2. Association of risk of VAP among ventilated patients in control group with their selected 
demographic variables. 
3. Association of risk of VAP among ventilated patients in experimental group with their 
selected clinical variables. 
4. Association of risk of VAP among ventilated patients in control group with their selected 
clinical variables. 
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SECTION: A 
Table: 4.A.1: Frequency and percentage distribution of ventilated patients based on their 
socio-demographic variables.        (N=60) 
S.No 
Socio-demographic 
variables 
Experimental group 
(n=30) 
Control group 
(n=30) 
  f % f % 
1. Age in years     
 a) ≤20 – 30 4 13.33 5 16.66 
 b) 31 – 40 2 6.66 3 10 
 c) 41 – 50 5 16.66 7 23.33 
 d) 51 and above 19 63.33 15 50 
2. Gender     
 a) Male 23 76.66 23 76.66 
 b) Female 7 23.33 7 23.33 
3. Educational status     
 a) Illiterate 9 30 10 33.33 
 b) Literate 21 70 20 66.66 
4. Income (per month)     
 a) 1000 – 4000 3 10 0 0 
 b) 4001 – 8000 9 30 8 26.66 
 c) 8001 – 12000 10 33.33 11 36.66 
 d) 12000 and above 8 26.66 11 36.66 
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5. Marital status 
 a) Married 24 80 22 73.33 
 b) Unmarried 6 20 8 26.66 
6. Occupation     
 a) Coolie 4 13.33 6 20 
 b) Private employee 8 26.66 9 30 
 c) Government employee 7 23.33 5 16.66 
 d) House wife 3 10 5 16.66 
 e) Retired 8 26.66 5 16.66 
 
Table 4.A.1 divulges that among 60 ventilated patients, majority 19(63.33%) and 
15(50%) of patients were between 51-60 and above years of age group in the experimental and 
control group respectively. 
 Regarding the gender, majority of patients, 23(76.66%) were male in both experimental 
and control groups. 
 In context of educational status, most of the patients were literate, 21(70%) and 
20(66.66%) in experimental and control groups respectively. 
 While portraying the marital status, majority of the patients 24(80%) and 22(73.33%) 
were married in experimental and control groups respectively. 
 While seeing the type of occupation, majority of the patients were private employee 
8(26.66%) in the experimental group and 9(30%) in the control group. 
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 In context of income, most of the patients earn between Rs.8000 and Rs.12000 per 
month, 10(30%) in the experimental group and 11(36.66%) in the control group. 
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Table: 4.A.2: Frequency and percentage distribution of ventilated patients based on their 
clinical variables.          (N=60) 
S.No Clinical variables 
Experimental group 
(n=30) 
Clinical group 
(n=30) 
  f % f % 
1. Personal habit of     
 a) Smoking 4 18.33 5 16.66 
 b) Alcoholism 5 16.66 4 13.33 
 c) Both 13 43.33 12 40 
 d) None 8 26.66 9 30 
2. Known history of     
 a) Pulmonary infection 5 16.66 3 10 
 b) Neurological infection 8 26.66 8 26.66 
 c) Systemic infection 5 16.66 5 16.66 
 d) None 12 40 14 46.66 
3. Glasgow coma scale     
 a) 13 – 15 0 0 0 0 
 b) 8 – 12 10 33.33 11 36.66 
 c) Less than 8 20 46.66 19 63.33 
4. Use of anesthetic drugs     
 a) Relaxant drugs 6 20 5 16.66 
 b) Sedative drugs 10 46.66 11 36.66 
 c) Both 14 33.33 14 46.66 
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5. Group of antibiotics 
received 
    
 a) Narrow spectrum 6 20 3 10 
 b) Broad spectrum 14 46.66 15 50 
 c) Both 10 33.33 12 40 
6. Administration of 
prophylactic drug 
    
 a) Sucralfate 0 0 0 0 
 b) Pantoprazole 20 66.66 21 70 
 c) Ranitidine 10 33.33 9 30 
7. Type of diagnosis     
 a) Neurologic disorder 11 36.66 10 33.33 
 b) Respiratory disorder 3 10 3 10 
 c) Trauma 13 43.33 10 33.33 
 d) Cardiovascular disorder 3 10 6 20 
 e) Poisoning 0 0 1 3.33 
 f) Others 0 0 0 0 
8. Reason for intubation     
 a) Respiratory failure 8 26.66 7 23.33 
 b) Airway protection 12 40 14 46.66 
 c) Hemodynamic instability 10 33.33 9 30 
9. Type of intubation     
 a) Emergency 14 46.66 12 40 
 b) Elective 16 53.33 18 60 
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Table 4.A.2 divulges that among 60 ventilated patients, majority 13(30%) and 12(33%) 
of patients were both alcoholic and smoker in the experimental and control group respectively. 
 Regarding the Known history of infection, highest 12(40%) and 14(46.66%) of patients 
had no previous history of infection in the experimental and control groups. 
 In context of Glasgow coma scale reading, most of the patients, 20(66.66%) and 
19(63.33%) were having GCS of 8 and below in experimental and control groups respectively. 
 While portraying the use of anesthetic drugs, majority 14(46.66%) of patients were 
getting both sedatives and relaxant drugs both in experimental and control groups. 
 In context of the group of antibiotics given, 14(46.66%) and 15(50%) of patients were 
getting broad spectrums of antibiotics were given in experimental and control groups 
respectively. 
 Considering the administration of prophylactic drugs, majority of the patients were 
getting Pantoprazole 20(66.66%) and 21(70%) in the experimental and control groups 
respectively. 
 While seeing the type of diagnosis, majority of the patients were admitted with Trauma 
13(43.33%) and 10(33.33%) in the experimental and control groups respectively. 
 Regarding the reason for intubation, most of the patients were intubated for airway 
protection 12(40%) and 14 (46.66%) in the experimental and control groups respectively. 
 While portraying the type of intubation, majority patients were electively intubated 
16(53.33%) and 18(60%) in the experimental and control groups respectively. 
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Fig :4.1. Distribution of ventilated patients based on their risk of ventilator associated 
pneumonia in the experimental group.       (n=30) 
 
 
 
 
 
 
 
 
Figure 4.1 signifies the frequency and percentage of pre-test, post-test-1 and post-test-
2risk of VAP among the ventilated patients. Out of the total 30 patients in the experimental 
group after the implementation of comprehensive interventional package, in the pre-test majority 
of the patient 27 (90%) had mild risk, 3 (10%) had no risk and none had moderate or high risk. 
Whereas in the post-test-1 most of the patients 24 (80%) had mild risk, 2 (6.66%) had no risk, 4 
(13.33%) had moderate risk and none had high risk. Similarly in the post-test-2 majority of 
patients 24 (80%) had mild risk, 3 (10%) had moderate risk, 3 (10%) had no risk and none had 
high risk. 
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Fig :4.2. Distribution of ventilated patients based on their risk of ventilator associated 
pneumonia in the control group.        (n=30) 
 
 
 
 
 
 
 
 
 Figure 4.2 signifies the frequency and percentage of pre-test, post-test-1 and post-test-
2risk of VAP among the ventilated patients. Out of the total 30 patients in the control group, in 
the pre-test relatively a high proportion of the patients 27 (90%) had mild risk, 3 (10%) had no 
risk and none of them had moderate or high risk. Whereas in the post-test-1 majority of the 
patient 16 (53.33%) had moderate risk, 14 (46.66%) had mild risk and none of them had no risk 
or high risk. Whereas in post-test-2 most of the patient 18 (60%) had moderate risk, 6 (20%) had 
high risk, 6 (20%) had mild risk and none of them had no risk. 
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SECTION: B 
Table 4.B.1. Mean score difference of pre-test and post-test-1 on risk of VAP among 
ventilated patients in experimental group.       (n=30) 
Experimental 
group 
Risk of VAP 
Mean S.D Mean % M.D 
Pre-test 1.83 0.854 18.3 
0.47 
Post-test 1 2.3 1.069 23 
 
Table 4.B.1 displays the mean score difference of pre-test and post-test-1 on risk of VAP 
among ventilated patients in the experimental group. The results show that the post-test-1 mean 
score (2.3±1.069) was higher than the pre-test mean score (1.83±0.854) with the mean difference 
of 0.47. 
 The result inferred that the patients in experimental group have not developed risk of 
VAP after the implementation of comprehensive interventional package. 
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Table 4.B.2. Mean score difference of pre-test and post-test-1 on risk of VAP among 
ventilated patients in control group.       (n=30) 
Control group 
Risk of VAP 
Mean S.D Mean % M.D 
Pre-test 1.73 0.926 17.3 
1.5 
Post-test 1 3.23 1.228 32.3 
 
Table 4.B.2 elucidates the mean score difference between pre-test and post-test-1on risk 
of VAP in the control group. The findings show that the pre-test mean score (1.73±0.926) was 
much lower than the post-test-1 mean score (3.23±1.228) with the mean score difference of 1.5. 
 This result shows that the patients in control group have developed the risk of VAP 
without the implementation of comprehensive interventional package. 
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Table 4.B.3. Mean score difference in risk of VAP between pre-test and post-test-1 in the 
control and experimental groups.        (n=30) 
Group 
Risk of VAP 
Mean S.D Mean % M.D 
Experimental 2.3 1.069 23 
0.93 
Control 3.23 1.228 32.3 
 
Table 4.B.3 presents the comparison of the mean score difference between pre-test and 
post-test-1 in the control and experimental group. In the control group, post-test-1 mean score 
(3.23±1.228) has increased than the experimental group post-test-1 mean score (2.3±1.069) with 
the mean score difference of 0.93. 
 This result signifies that there is a difference between the post-test-1 mean score risk of 
VAP in the control group and the post-test-1 mean score of risk of VAP in experimental group, 
which implies that the comprehensive interventional package is effective. 
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Table 4.B.4. Mean score difference of pre-test and post-test-2 on risk of VAP among 
ventilated patients in experimental group.            (n=30) 
Experimental 
group 
Risk of VAP 
Mean S.D Mean % M.D 
Pre-test 1.83 0.854 18.3 
0.3 
Post-test 2 2.13 1.095 21.3 
 
Table 4.B.4 displays the mean score difference of pre-test and post-test-2 on risk of VAP 
among ventilated patients in the experimental group. The results show that the post-test-2 mean 
score (2.13±1.095) was higher than the pre-test mean score (1.83±0.854) with the mean 
difference of 0.3. 
 The result implies that the patients had not developed risk of VAP in the experimental 
group after the implementation of comprehensive interventional package. 
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Table 4.B.5. Mean score difference of pre-test and post-test-2 on risk of VAP among 
ventilated patients in control group.       (n=30) 
Control group 
Risk of VAP 
Mean S.D Mean % M.D 
Per-test 1.73 0.926 17.3 
3.63 
Post-test 2 5.36 2.448 53.6 
 
Table 4.B.5 elucidates the mean score difference between pre-test and post-test-2on risk 
of VAP in the control group. The findings show that the pre-test mean score (1.73±0.926) was 
much lower than the post-test-2 mean score (5.36±2.448) with the mean score difference of 3.63. 
 This shows that the patients in control group have developed risk of VAP without the 
implementation of comprehensive interventional package. 
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Table 4.B.6. Mean score difference in risk of VAP between pre-test and post-test-2 in the 
control and experimental groups.        (n=30) 
Group 
Risk of VAP 
Mean S.D Mean % M.D 
Experimental 2.13 1.095 21.3 
3.23 
Control 5.36 2.448 53.6 
 
Table 4.B.6 presents the comparison of the mean score difference between pre-test and 
post-test-2 in the control and experimental group. In the control group, post-test-2 mean score 
(5.36±2.448) has increased than the experimental group post-test-2 mean score (2.13±1.095) 
with the mean score difference of 3.23. 
 This result signifies that there is a difference between the post-test-2 mean score risk of 
VAP in the control group and the post-test-2 mean score of risk of VAP in experimental group, 
which implies that the comprehensive interventional package is effective in preventing the risk 
of VAP.. 
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Table 4.B.7. Mean score difference of post-test-1 and post-test-2 on risk of VAP among 
ventilated patients in experimental group.            (n=30) 
Experimental 
group 
Risk of VAP 
Mean S.D Mean % M.D 
Post-test 1 2.3 1.069 23 
0.17 
Post-test 2 2.13 1.095 21.3 
 
Table 4.B.7 displays the mean score difference of post-test-1 and post-test-2 on risk of 
VAP among ventilated patients in the experimental group. The results show that the post-test-2 
mean score (2.13±1.095) was higher than the post-test-1 mean score (2.3±1.069) with the mean 
difference of 0.17. 
 The result inferred that the patient in experimental group has not developed risk of VAP 
after the implementation of comprehensive interventional package. 
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Table 4.B.8. Mean score difference of post-test-1 and post-test-2 on risk of VAP among 
ventilated patients in control group.       (n=30) 
Control group 
Risk of VAP 
Mean S.D Mean % M.D 
Post-test 1 3.23 1.228 32.3 
2.13 
Post-test 2 5.36 2.448 53.6 
 
Table 4.B.8 elucidates the mean score difference between post-test-1 and post-test-2on 
risk of VAP in the control group. The findings show that the post-test-1 mean score (3.23±1.228) 
was lower than the post-test-2 mean score (5.36±2.448) with the mean score difference of 2.13. 
This result implies that the patients in control group have developed the risk of VAP 
without the implantation of comprehensive interventional package. 
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Table 4.B.9. Mean score difference in risk of VAP between post-test-1 and post-test-2 in the 
control and experimental groups.        (n=30) 
Group 
Risk of VAP 
Mean S.D Mean % M.D 
Experimental 2.13 1.095 21.3 
3.23 
Control 5.36 2.448 53.6 
 
Table 4.B.9 presents the comparison of the mean score difference between post-test-1 and 
post-test-2 in the control and experimental group. In the control group, post-test-2 mean score 
(5.36±2.448) has increased than the experimental group post-test-2 mean score (2.13±1.095) 
with the mean score difference of 3.23. 
 This result signifies that there is a difference between the post-test-2 mean score risk of 
VAP in the control group and the post-test-2 mean score of risk of VAP in experimental group, 
which means that the comprehensive interventional package is effective. 
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Table 4.B.10. Paired‘t’ test on risk of VAP among ventilated patients in pre-test and post-
test-1 within the experimental group.       (n=30) 
Experimental 
group 
Mean S.D ‘t’ value ‘p’ value 
Pre-test 1.83 0.854 
3.58 0.005 
Post-test 1 2.3 1.069 
***(p<0.001) 
Table 4.B.10 reveals that the paired‘t’ test score on risk of VAP within the experimental 
group is 3.58 and P=0.005 at p<0.001 level. This indicates that this difference is not significant 
within the pre-test and post-test-1 score. 
The above finding clearly implies that comprehensive interventional package was 
effective in preventing the risk of ventilator associated pneumonia. Thus, the research hypothesis 
H2 is accepted. 
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Table 4.B.11. Paired‘t’ test on risk of VAP among ventilated patients in pre-test and post-
test-2 within the experimental group.       (n=30) 
Experimental 
group 
Mean S.D ‘t’ value ‘p’ value 
Pre-test 1.83 0.854 
1.8 0.41 
Post-test 2 2.13 1.095 
***(p<0.001) 
Table 4.B.11 reveals that the paired‘t’ test score on risk of VAP within the experimental 
group is 1.8 and P=0.041 at p<0.001 level. This indicates that this difference is not significant 
within the pre-test and post-test-2 score. 
The above finding clearly implies that comprehensive interventional package was 
effective in preventing the risk of ventilator associated pneumonia. Thus, the research hypothesis 
H2 is accepted. 
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Table 4.B.12. Paired‘t’ test on risk of VAP among ventilated patients in post-test-1 and 
post-test-2 within the experimental group.      (n=30) 
Experimental 
group 
Mean S.D ‘t’ value ‘p’ value 
Post-test 1 2.3 1.069 
0.54 0.296 
Post-test 2 2.13 1.095 
***(p<0.001) 
Table 4.B.12 reveals that the paired‘t’ test score on risk of VAP within the experimental 
group is 0.54 and P=0.296 at p<0.001 level. This indicates that this difference is not significant 
within the post-test-1 and post-test-2 score. 
The above finding clearly implies that comprehensive interventional package was 
effective in preventing the risk of ventilator associated pneumonia. Thus, the research hypothesis 
H2 is accepted. 
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Table 4.B.13. Paired‘t’ test on risk of VAP among ventilated patients in pre-test and post-
test-1 within the control group.        (n=30) 
Control group Mean S.D ‘t’ value ‘p’ value 
Pre-test 1.73 0.926 
7.14 0.000*** 
Post-test 1 3.23 1.228 
***(p<0.001) 
Table 4.B.13 depicts that the paired‘t’ test score on risk of VAP within the control group 
is 7.14 and P=0.000 at p<0.001 level, which indicates that this difference is considered to be 
highly significant within the pre-test and post-test-1 score. 
The above finding implies that patients had developed the risk of ventilator associated 
pneumonia without the implementation of comprehensive interventional package. Thus the 
research hypothesis is H2 is accepted. 
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Table 4.B.14. Paired‘t’ test on risk of VAP among ventilated patients in pre-test and post-
test-2 within the control group        (n=30) 
Control group Mean S.D ‘t’ value ‘p’ value 
Pre-test 1.73 0.926 
7.56 0.000*** 
Post-test 2 5.36 2.448 
***(p<0.001) 
Table 4.B.14 depicts that the paired‘t’ test score on risk of VAP within the control group 
is 7.56 and P=0.000 at p<0.001 level, which indicates that this difference is considered to be 
highly significant within the pre-test and post-test-2 score. 
The above finding implies that patients had developed the risk of ventilator associated 
pneumonia without the implementation of comprehensive interventional package. Thus the 
research hypothesis is H2 is accepted. 
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Table 4.B.15. Paired‘t’ test on risk of VAP among ventilated patients in post-test-1 and 
post-test-2 within the control group.       (n=30) 
Control group Mean S.D ‘t’ value ‘p’ value 
Post-test 1 3.23 1.228 
5.38 0.000*** 
Post-test 2 5.36 2.448 
***(p<0.001) 
Table 4.B.15 depicts that the paired‘t’ test score on risk of VAP within the control group 
is 5.38 and P=0.000 at p<0.001 level, which indicates that this difference is considered to be 
highly significant within the post-test-1 and post-test-2 score. 
The above finding implies that patients had developed the risk of ventilator associated 
pneumonia without the implementation of comprehensive interventional package. Thus the 
research hypothesis is H2 is accepted. 
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Table 4.B.16. Independent‘t’ test for comparison of risk of VAP in pre-test and post-test-1 
between experimental and control group.       (n=30) 
Group Mean S.D ‘t’ value ‘p’ value 
Experimental 2.3 1.069 
3.141 0.002 
Control 3.23 1.228 
***(p<0.001) 
Table 4.B.16 reveals the comparison of risk of VAP between control group and 
experimental group. The findings show overall independent‘t’ test score being 3.141 and 
P=0.002 at p<0.001 level. This indicates that this difference is not significant within the pre-test 
and post-test-1 score. 
The finding implies that comprehensive interventional package was effective in 
preventing the risk of ventilator associated pneumonia in experimental group after the 
implementation of comprehensive interventional package. Thus the research hypothesis H2 is 
accepted. 
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Table 4.B.17. Independent‘t’ test for comparison of risk of VAP in pre-test and post-test-2 
between experimental and control group.       (n=30) 
Group Mean S.D ‘t’ value ‘p’ value 
Experimental 2.13 1.095 
8.136 0.000*** 
Control 5.36 2.448 
***(p<0.001) 
Table 4.B.17 reveals the comparison of risk of VAP between control group and 
experimental group. The findings show overall independent‘t’ test score being 8.136 and 
P=0.000 at p<0.001 level. This indicates that this difference is not significant within the pre-test 
and post-test-2 score. 
The finding implies that comprehensive interventional package was effective in 
preventing the risk of ventilator associated pneumonia in experimental group after the 
implementation of comprehensive interventional package. Thus the research hypothesis H2 is 
accepted. 
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Table 4.B.18. Independent‘t’ test for comparison of risk of VAP in post-test-1 and post-test-
2 between experimental and control group.      (n=30) 
Group Mean S.D ‘t’ value ‘p’ value 
Experimental 2.13 1.095 
8.136 0.000*** 
Control 5.36 2.448 
***(p<0.001) 
Table 4.B.18 reveals the comparison of risk of VAP between control group and 
experimental group. The findings show overall independent‘t’ test score being 8.136 and 
P=0.000 at p<0.001 level. This indicates that this difference is not significant within the post-
test-1 and post-test-2 score. 
The finding implies that comprehensive interventional package was effective in 
preventing the risk of ventilator associated pneumonia in experimental group after the 
implementation of comprehensive interventional package. Thus the research hypothesis H2 is 
accepted. 
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SECTION: C 
Table 4.C.1. Association between risk of VAP and demographic variables of patients in 
experimental group.           (n=30) 
S.No 
Socio-
demographic 
variables 
No risk Mild risk Moderate 
risk 
High risk 2 
‘p’ 
value 
  f % f % f % f %   
1. Age in years           
 a) ≤20 – 30 0 0 4 13.33 0 0 0 0 
0.827 
0.999 
NS 
 b) 31 – 40 0 0 2 6.66 0 0 0 0 
 c) 41 – 50 0 0 5 16.66 0 0 0 0 
 d) 51 – 60 3 10 16 53.33 0 0 0 0 
2. Gender           
 a) Male 2 6.66 21 70 0 0 0 0 
0.185 
0.980 
NS  b) Female 1 3.33 6 20 0 0 0 0 
3. Educational status           
 a) Illiterate 2 6.66 7 23.33 0 0 0 0 
2.133 
0.545 
NS  b) Literate 1 3.33 20 66.66 0 0 0 0 
4. Income (per 
month) 
          
 a) 1000 – 4000 1 3.33 2 6.66 0 0 0 0 
1.914 
0.992 
NS 
 b) 4001 – 8000 1 3.33 8 26.66 0 0 0 0 
 c) 8001 – 12000 1 3.33 9 30 0 0 0 0 
74 
 
 d) above 12000 0 0 8 26.66 0 0 0 0 
5. Marital status           
 a) Married 3 10 21 70 0 0 0 0 
0.232 
0.972 
NS  b) Unmarried 0 0 6 20 0 0 0 0 
6. Occupation           
 a) Coolie 0 0 4 13.33 0 0 0 0 
2.209 
0.999 
NS 
 b) Private 
employee 
1 3.33 7 23.33 0 0 0 0 
 c) Govt. employee 0 0 7 23.33 0 0 0 0 
 d) House wife 0 0 3 10 0 0 0 0 
 e) Retired 2 6.66 6 20 0 0 0 0 
Note: significant at * p<0.05 level 
Table 4.C.1.presents the association between the selected demographic variables with 
pre-test risk of VAP among ventilated patients in experimental group, which infers that there is 
no association at 0.05 level. Hence the Research Hypothesis (H3) is rejected. 
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Table 4.C.2. Association between risk of VAP and demographic variables of patients in 
control group.           (n=30) 
S.No 
Socio-
demographic 
variables 
No risk Mild risk Moderate 
risk 
High risk 2 
‘p’ 
value 
  f % f % f % f %   
1. Age in years           
 a) ≤20 – 30 1 3.33 4 13.33 0 0 0 0 
0.864
0.999 
NS 
 b) 31 – 40 0 0 3 10 0 0 0 0 
 c) 41 – 50 1 3.33 6 20 0 0 0 0 
 d) 51 – 60 1 3.33 14 46.66 0 0 0 0 
2. Gender           
 a) Male 2 6.66 21 70 0 0 0 0 
0.185
0.980 
NS  b) Female 1 3.33 6 20 0 0 0 0 
3. Educational 
status 
          
 a) Illiterate 1 3.33 9 30 0 0 0 0 
0 
1.000 
NS  b) Literate 2 6.66 18 60 0 0 0 0 
4. Income (per 
month) 
          
 a) 1000 – 4000 0 0 0 0 0 0 0 0 
0.075
1.000 
NS 
 b) 4001 – 8000 1 3.33 7 23.33 0 0 0 0 
 c) 8001 – 12000 1 3.33 10 33.33 0 0 0 0 
 d) above 12000 1 3.33 10 33.33 0 0 0 0 
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5. Marital status           
 a) Married 2 6.66 20 66.66 0 0 0 0 
0.075
0.994 
NS  b) Unmarried 1 3.33 7 23.33 0 0 0 0 
6. Occupation           
 a) Coolie 1 3.33 5 16.66 0 0 0 0 
1.56 
0.999 
NS 
 b) Private 
employee 
0 0 9 30 0 0 0 0 
 c) Govt. 
employee 
1 3.33 4 13.33 0 0 0 0 
 d) House wife 1 3.33 4 13.33 0 0 0 0 
 e) Retired 0 0 5 16.66 0 0 0 0 
Note: significant at * p<0.05 level 
Table 4.C.2.presents that there was no significant association between risk of VAP and 
the selected demographic variables in the control group at 0.05 level stating that the research 
Hypothesis (H3) is rejected. 
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Table 4.C.3. Association between risk of VAP and clinical variables in experimental group.  
            (n=30) 
S.No Clinical variables No risk Mild risk Moderate 
risk 
High 
risk 
2 
‘p’ 
value 
  F % f % F % F %   
1. Personal habit of           
 a) Smoking 0 0 4 13.33 0 0 0 0 
0.818 
0.999 
NS 
 b) Alcoholism 0 0 5 16.66 0 0 0 0 
 c) Both 2 6.66 11 36.66 0 0 0 0 
 d) None 1 3.33 7 23.33 0 0 0 0 
2. Known history of           
 a) Pulmonary 
infection 
0 0 5 16.66 0 0 0 0 
0.701 
0.999 
NS 
 b) Neurological 
disorder 
1 3.33 7 23.33 0 0 0 0 
 c) Systemic 
infection 
1 3.33 4 13.33 0 0 0 0 
 d) None 1 3.33 11 36.66 0 0 0 0 
3. Glasgow comma 
scale 
          
 a) 13-15 0 0 0 0 0 0 0 0 
0.666 
0.995 
NS 
 b) 8-12 0 0 10 33.33 0 0 0 0 
 c) less than 12 3 10 17 56.66 0 0 0 0 
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4. Use of anesthetic 
drugs 
 a) Relaxant drug 0 0 6 20 0 0 0 0 
0.351 
0.999 
NS 
 b) Sedation 1 3.33 9 30 0 0 0 0 
 c) Both 2 6.66 12 40 0 0 0 0 
5. Group of 
antibiotics 
receiving 
          
 a) Narrow 
spectrum 
0 0 6 20 0 0 0 0 
0.403 
0.998 
NS  b) Broad spectrum 1 3.33 13 43.33 0 0 0 0 
 c) Both 2 6.66 8 26.66 0 0 0 0 
6. Administration of 
prophylactic drugs 
          
 a) Sucralfate 0 0 0 0 0 0 0 0 
0 
1.000 
NS 
 b) Pantoprazole 2 6.66 18 60 0 0 0 0 
 c) Ranitidine 1 3.33 9 30 0 0 0 0 
7. Type of diagnosis           
 a) Neurological 
disorder 
1 3.33 10 33.33 0 0 0 0 
10.887 
0.760 
NS 
 b) Respiratory 
disorder 
0 0 3 10 0 0 0 0 
 c) Trauma 0 0 13 43.33 0 0 0 0 
 d) Cardiovascular 
disorder 
2 6.66 1 3.33 0 0 0 0 
 e) Poisoning 0 0 0 0 0 0 0 0 
 f) Others 0 0 0 0 0 0 0 0 
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8. Reason for 
intubation 
          
 a) Respiratory 
failure 
1 3.33 7 23.33 0 0 0 0 
0.758 
0.993 
NS 
 b) Airway 
protection 
2 6.66 10 33.33 0 0 0 0 
 c) Hemodynamic 
instability 
0 0 10 33.33 0 0 0 0 
9. Type of intubation           
 a) Emergency 2 6.66 12 40 0 0 0 0 
0.565 
0.904 
NS  b) Elective 1 3.33 15 50 0 0 0 0 
Note: significant at * p<0.05 level 
Table 4.C.3. presents that there is no significant association between the pre-test risk of 
VAP in experimental group and selected clinical demographic variables at p<0.05level. Hence 
the Research Hypothesis (H3) is rejected. 
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Table 4.C.4. Association between risk of VAP and clinical variables in control group.  
            (n=30) 
S.No Clinical variables No risk Mild risk Moderate 
risk 
High 
risk 
2 
‘p’ 
value 
  f % f % F % F %   
1. Personal habit of           
 a) Smoking 1 3.33 4 13.33 0 0 0 0 
0647 
0.999 
NS 
 b) Alcoholism 0 0 4 13.33 0 0 0 0 
 c) Both 1 3.33 11 36.66 0 0 0 0 
 d) None 1 3.33 8 26.66 0 0 0 0 
2. Known history of           
 a) Pulmonary 
infection 
0 0 3 10 0 0 0 0 
2.207 
0.987 
NS 
 b) Neurological 
disorder 
0 0 8 26.66 0 0 0 0 
 c) Systemic 
infection 
0 0 5 16.66 0 0 0 0 
 d) None 3 10 11 36.66 0 0 0 0 
3. Glasgow comma 
scale 
          
 a) 13-15 0 0 0 0 0 0 0 0 
0.015 
1.000 
NS 
 b) 8-12 1 3.33 10 33.33 0 0 0 0 
 c) less than 12 2 6.66 17 56.66 0 0 0 0 
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4. Use of anesthetic 
drugs 
 a) Relaxant drug 1 3.33 4 13.33 0 0 0 0 
0.691 
0.994 
NS 
 b) Sedation 1 3.33 10 33.33 0 0 0 0 
 c) Both 1 3.33 13 43.33 0 0 0 0 
5. Group of 
antibiotics 
receiving 
          
 a) Narrow 
spectrum 
1 3.33 2 6.66 0 0 0 0 
2.034 
0.916 
NS  b) Broad spectrum 1 3.33 14 46.66 0 0 0 0 
 c) Both 1 3.33 11 36.66 0 0 0 0 
6. Administration of 
prophylactic drugs 
          
 a) Sucralfate 0 0 0 0 0 0 0 0 
5.677 
0.460 
NS 
 b) Pantoprazole 0 0 21 70 0 0 0 0 
 c) Ranitidine 3 10 6 20 0 0 0 0 
7. Type of diagnosis           
 a) Neurological 
disorder 
2 6.66 8 26.66 0 0 0 0 
1.221 
1.000 
NS 
 b) Respiratory 
disorder 
0 0 3 10 0 0 0 0 
 c) Trauma 1 3.33 9 30 0 0 0 0 
 d) Cardiovascular 
disorder 
0 0 6 20 0 0 0 0 
 e) Poisoning 0 0 1 3.33 0 0 0 0 
 f) Others 0 0 0 0 0 0 0 0 
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8. Reason for 
intubation 
          
 a) Respiratory 
failure 
1 3.33 6 20 0 0 0 0 
0.527 
0.997 
NS 
 b) Airway 
protection 
2 6.66 12 40 0 0 0 0 
 c) Hemodynamic 
instability 
0 0 9 30 0 0 0 0 
9. Type of intubation           
 a) Emergency 1 3.33 11 36.66 0 0 0 0 
0.06 
0.996 
NS  b) Elective 2 6.66 16 53.33 0 0 0 0 
Note: significant at * p<0.05 level 
Table 4.C.4.shows no significant association between selected clinical variables with pre-
test risk of VAP among ventilated patients in the control group at 0.05 level, stating that the 
Research Hypothesis (H3) is rejected with regards to all variables. 
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CHAPTER V 
DISCUSSION 
This chapter presents the discussion part in relation to the similar studies conducted by 
other researcher. The main aim of the study was to evaluate the impact of comprehensive 
interventional package to identify the risk of ventilator associated pneumonia among ventilated 
patients. This study was conducted using quasi experimental design. Subjects were selected by 
convenience sampling method. The sample size was 60. Risk assessment tool for VAP tool was 
used to identify the risk of ventilator associated pneumonia among ventilated patients. The 
results were analyzed through descriptive measures (mean, frequency, percentage, standard 
deviation) and inferential statistics (chi-square, ‘t’ test).  
As nurses roles change in response to the dynamics of managed care and an increase in 
use of advanced technology and nursing care, more is expected of them both in terms of 
psychomotor and cognitive skills. Critically thinking is currently a highly valued educational 
outcome throughout the educational and clinical settings, especially in relation to higher and 
professional standards. 
The discussion is based on the objectives and Hypothesis specified in this study. 
Objectives of the study were to 
1. To assess the risk of ventilator associated pneumonia before and after implementation of 
comprehensive interventional package among patients in control and experimental group. 
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2. To determine the impact of comprehensive interventional package on ventilator 
associated pneumonia risk by comparing pre-test and post-test scores among control and 
experimental group. 
3. To determine the impact of comprehensive interventional package on ventilator 
associated pneumonia risk by comparing post-test scores between the control and 
experimental group. 
4. To find out the association between the risks of ventilator associated pneumonia among 
ventilated patients with their selected demographic and clinical variables in control and 
experimental group. 
Hypothesis of the study were to 
1. There is a significant difference in the pre-test and post-test score among control and 
experimental group before and after implementation of comprehensive interventional 
package. 
2. The mean post-test score of risk of ventilator associated pneumonia is significantly higher 
among the ventilated patients in experimental group than the ventilated patients in the 
control group. 
3. There is a statistically significant association between risk of ventilator associated 
pneumonia with selected demographic and clinical variables in both control and 
experimental group. 
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The first objective of this study was to assess the risk of ventilator associated 
pneumonia before and after implementation of comprehensive interventional package 
among patients in control and experimental group. 
The above objective of the study was to identify the risk of Ventilator Associated 
Pneumonia among the mechanically ventilated patients before and after implementation of 
comprehensive interventional package. 
In the experimental group, Out of the total 30 patients after the implementation of 
comprehensive interventional package, in the pre-test majority of the patient 27 (90%) had mild 
risk, 3 (10%) had no risk and none had moderate or high risk. Whereas in the post-test-1 most of 
the patients 24 (80%) had mild risk, 2 (6.66%) had no risk, 4 (13.33%) had moderate risk and 
none had high risk. Similarly in the post-test-2 majority of patients 24 (80%) had mild risk, 3 
(10%) had moderate risk, 3 (10%) had no risk and none had high risk. 
 Whereas in the control group, Out of the total 30 patients, in the pre-test relatively a high 
proportion of the patients 27 (90%) had mild risk, 3 (10%) had no risk and none of them had 
moderate or high risk. Whereas in the post-test-1 majority of the patient 16 (53.33%) had 
moderate risk, 14 (46.66%) had mild risk and none of them had no risk or high risk. Whereas in 
post-test-2 most of the patient 18 (60%) had moderate risk, 6 (20%) had high risk, 6 (20%) had 
mild risk and none of them had no risk. 
This study was supported with a study done by Virginia Bonsal Cooper et.al. (2013), she 
conducted a prospective study on incidence and risk factor for ventilator associated pneumonia 
in critically ill patients in Canada. Data was collected from 16 ICUs to determine the conditional 
probability and cumulative risk over the duration of stay in the ICUs. The sample was 1014 
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mechanically ventilated patients. The results showed that 177 (17.5%) patients developed higher 
risk for ventilator associated pneumonia, whereas 526 (51.87%) patients developed moderate 
risk for ventilator associated pneumonia and 311 (30.67%) developed mild risk after the ICU 
admission. 
This was also supported by the study done by Tsai.el.al. (2008), who conducted a 
prospective evaluation of usefulness of intermittent suctioning of oral secretions before each 
position change in reducing VAP. A time sequence non randomized intervention design was 
used. After a duration of 9 month observation phase and 6 month education phase, followed by a 
7 month intervention phase the occurrence of VAP rate was reduced in studied group (6 of 227 
patients, 2.6%) than control group (26 of 237 patients, 11%) (p<0.001). The incidence of VAP in 
control and study group was 6.51 and 2.04 per 1000 ventilated days respectively (p=0.002). The 
results revealed that intermittent suction of oral secretion before each position change proved to 
be effective in reducing VAP. 
The second objectives of the study was to determine the impact of comprehensive 
interventional package on ventilator associated pneumonia risk by comparing pre-test and 
post-test scores among control and experimental group. 
The above objective of the study was to determine the impact of comprehensive 
interventional package on risk of ventilator associated pneumonia. 
In the experimental group, out of 30 patients after the implementation of comprehensive 
interventional package, the mean score for risk of Ventilator Associated Pneumonia in pre-test 
was (1.83±0.854), mean post-test-1 score was (2.3±1.069) and mean post-test-2 score was 
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(2.13±1.095), with a mean difference of 0.47 (pre-test and post-test-1), 0.3 (pre-test and post-
test-2) and 0.17 (post-test-1 and post-test-2). 
In the control group, out of 30 patients the mean pre-test score for risk of Ventilator 
Associated Pneumonia was (1.73±0.926), mean post-test-1 score was (3.23±1.228) and mean 
post-test-2 score was (5.36±2.448), with a mean difference of 1.5 (pre-test and post-test-1), 3.63 
(pre-test and post-test-2) and 2.13 (post-test-1 and post-test-2). 
This above findings implies that comprehensive interventional package is effective in 
reducing the risk of ventilator associated pneumonia among mechanically ventilated patients. 
The finding of the present study was supported with a study done by Christine Ilson et.al. 
(20010), who conducted a study to assess the effectiveness of selective oropharyngeal 
decontamination on the risk of ventilator associated pneumonia. It suggested that chlorhexidine 
gluconate rinses for patients in experimental group might be beneficial in reducing bacteria in 
dental plaque, which may be a source of pathogens for development of ventilator associated 
pneumonia. The study reveals that out of 50 patients 29 (58%) had no risk, whereas 15 (30%) 
patients developed some risks and 6 (12%) developed high risk for ventilator associated 
pneumonia. Topically applied antibiotics, or chlorhexidine gluconate rinses may aid in reducing 
bacteria in mouth, potentially decreasing the risk for ventilator associated pneumonia. 
The third objective of the study was to determine the impact of comprehensive 
interventional package on ventilator associated pneumonia risk by comparing post-test 
score between the control and experimental group. 
Out of 60 patients in experimental and control group, the mean post-test-1 score 
(2.3±1.069) of the experimental group was found to be lower than the post-test-1 score 
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(3.23±1.228) of the control group, with the mean difference of 0.93, and the mean post-test-2 
score (2.13±1.095) of the experimental group was found to be lower than the post-test-2 score 
(5.36±2.448) of the control group, with the mean difference of 3.23 
Regarding the risk of Ventilator Associated Pneumonia, obtained from independent ‘t’ 
test value in the control and experimental group after the implementation of comprehensive 
interventional package on risk of Ventilator Associated Pneumonia was 3.141 (post-test-1) and 
8.136 (post-test-2) (p<0.001).  
Regarding risk of Ventilator Associated Pneumonia, obtained paired ‘t’ value of 
experimental group was 3.58, 1.8 and 0.54 at p<0.001 level, which indicates that this difference 
shows no significance and paired ‘t’ value of the control group was 7.14, 7.56 and 5.38, which is 
considered to be highly significant. It indicates that the risk of Ventilator Associated Pneumonia 
was prevented after the implementation of comprehensive interventional package in the 
experimental group. 
This was supported with a study conducted by Garcia et.al. (2009), she conducted a quasi 
experimental study to determine the effect of a comprehensive oral and dental care protocol on 
the rate of VAP by pre-post interventional study. Adults receiving mechanical ventilation more 
than 48 hours in Brookdale University Hospital were studied in a two consecutive 24 month 
periods. Pre-interventional group (n=779) had no oral assessments, no subglottic suctioning, no 
tooth brushing, and suctioning of secretions in oral cavity as needed. The interventional group 
(n=759) was treated with a protocol which included oral assessment, deep suctioning every 6 
hours, oral tissue cleaning every 4 hours or as needed and tooth brushing twice daily. VAP rate 
was determined using clinical pulmonary infection score (CPIS) (CPIS>6). The rate of VAP was 
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found to be 12% per 1000 ventilator days before the intervention and decreased to 8.0% per 1000 
ventilator days during the intervention (p=0.006). Research study results concluded that the 
implementation of comprehensive oral care protocol and staff compliance significantly reduced 
the VAP rate and its associated costs. 
The fourth objective of the study was to find out the association between the risks of 
ventilator associated pneumonia among ventilated patients with their selected demographic 
and clinical variables in control and experimental group. 
The findings of the study reveals the association between pre-test, post-test-1 and post-
test-2 risk of Ventilator Associated Pneumonia among mechanically ventilated patients with 
selected socio-demographic and clinical variables in both experimental and control group. 
There was no association between pre-test risk of Ventilator Associated Pneumonia with 
selected socio-demographic and clinical variables in both experimental and control group. Hence 
the Research Hypothesis H3 is rejected. 
Regarding post-test-1, there was no association between post-test-1 risk of Ventilator 
Associated Pneumonia with selected socio-demographic and clinical variables in both 
experimental and control group. Hence the Research Hypothesis H3 is rejected. 
Regarding post-test-2, there was no association between post-test-1 risk of Ventilator 
Associated Pneumonia with selected socio-demographic and clinical variables in both 
experimental and control group, except Gender and Occupation which shows significant 
association in experimental group. Hence the Research Hypothesis H3 is accepted. 
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This was supported by the study conducted by Shobha Gaikward et.al. (2000), she 
conducted a prospective observational study in NICU of CSM Medical University, Lucknow 
(UP) to assess aetilology and risk factors of VAP in neonates over a period of one year. Neonates 
admitted in NICU who required mechanical ventilation for more than 48 hours were enrolled in 
to the study the study group comprised of 98 neonates out of which,  30 neonates developed 
VAP (30.6%). VAP rates were 37.2 per 1000 days of mechanical ventilation. Most common 
bacterial organisms isolated from endotracheal aspirate of VAP patients were Klebsiella spp 
(32.8%), E coli (23.2%), and Acinobacter (17.8%). Multiple regression analysis revealed that 
duration of mechanical ventilation (OR 1.10, 95% CI 1.02, 1:21; P=0.021) and very low birth 
weight (OR 3.88, 95% CI 1.05, 14.34; P=0.042) were two statistically significant risk factors in 
predicting VAP. Results revealed that very low birth, prematurity, duration of mechanical 
ventilation, number of reintubations, and length of ICU stay were significantly associated with 
VAP in bivariate analysis. Showed the occurrence of VAP was less in experimental group as 
compared to control group. 
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CHAPTER VI 
SUMMARY AND RECOMMENDATIONS 
The essence of any research study is based on the study findings. A study is said to be 
incomplete, if its results are not communicated effectively to its users and consumers. This 
chapter deals with the summary and conclusion drawn. It focuses on the implications and gives 
recommendation for Nursing education, Nursing practice, Nursing administration and Nursing 
research. 
SUMMARY OF THE STUDY 
The main focus of the present study was to evaluate the impact of comprehensive 
interventional package to identify the risk of ventilator associated pneumonia among ventilated 
patients in selected hospital, Madurai. A quantitative approach was selected for this study. 
This was a quasi-experimental study in which pre-test and post-test control group design 
was adopted. Tool was developed and used for collecting data to assess the risk of ventilator 
associated pneumonia on ventilated patients. The reliability of the tool was established by test re-
test method. The tool was administered among mechanically ventilated patients in Vadamalayan 
Hospital and Velammal Medical College Hospital, Madurai. The tool was found to be reliable. 
The data gathered was analyzed and interpreted in terms of the study objectives. 
The main study was conducted in Vadamalayan Hospital and Velammal Medical College 
Hospital, Madurai for a period of ten weeks. The non-probability convenience sampling method 
was used for sampling technique procedure. Data was collected from the respondent, reorganized 
and interpreted using both descriptive and inferential statistics. 
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The objectives of the study were following 
1. To assess the risk of ventilator associated pneumonia before and after implementation of 
comprehensive interventional package among patients in control and experimental group. 
2. To determine the impact of comprehensive interventional package on ventilator 
associated pneumonia risk by comparing pre-test and post-test scores among control and 
experimental group. 
3. To determine the impact of comprehensive interventional package on ventilator 
associated pneumonia risk by comparing post-test scores between the control and 
experimental group. 
4. To find out the association between the risks of ventilator associated pneumonia among 
ventilated patients with their selected demographic and clinical variables in control and 
experimental group. 
The research hypothesis stated were, 
H1- There is a significant difference in the pre-test and post-test score among control and 
experimental group before and after implementation of comprehensive interventional package. 
H2- The mean post-test score of risk of ventilator associated pneumonia is significantly 
higher among the ventilated patients in experimental group than the ventilated patients in the 
control group. 
H3- There is a statistically significant association between risk of ventilator associated 
pneumonia with selected demographic and clinical variables in both control and experimental 
group. 
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Major findings of the study 
In the experimental group, Out of the total 30 patients after the implementation of 
comprehensive interventional package, in the pre-test majority of the patient 27 (90%) had mild 
risk, 3 (10%) had no risk and none had moderate or high risk. Whereas in the post-test-1 most of 
the patients 24 (80%) had mild risk, 2 (6.66%) had no risk, 4 (13.33%) had moderate risk and 
none had high risk. Similarly in the post-test-2 majority of patients 24 (80%) had mild risk, 3 
(10%) had moderate risk, 3 (10%) had no risk and none had high risk. The risk of Ventilated 
Associated Pneumonia risk score in pre-test was 1.83, post-test-1 was 2.3 and the post-test-2 was 
2.13. The paired ‘t’ test  for the risk of ventilated associated pneumonia was 3.58, 1.8 and 8.136, 
which shows there is no raise in the risk of Ventilated Associated Pneumonia  in the pre-test, 
post-test-1 and post-test-2 among experimental group after the implementation of comprehensive 
interventional package. 
Whereas in the control group, Out of the total 30 patients, in the pre-test relatively a high 
proportion of the patients 27 (90%) had mild risk, 3 (10%) had no risk and none of them had 
moderate or high risk. Whereas in the post-test-1 majority of the patient 16 (53.33%) had 
moderate risk, 14 (46.66%) had mild risk and none of them had no risk or high risk. Whereas in 
post-test-2 most of the patient 18 (60%) had moderate risk, 6 (20%) had high risk, 6 (20%) had 
mild risk and none of them had no risk. The risk of Ventilated Associated Pneumonia risk score 
in pre-test was 1.73, post-test-1 was 3.23 and the post-test-2 was 25.36. The paired ‘t’ test  for 
the risk of ventilated associated pneumonia was 7.14, 7.56 and 5.38, which shows there is raise 
in the risk of Ventilated Associated Pneumonia  in the pre-test, post-test-1 and post-test-2 among 
control group without the implementation of comprehensive interventional package. 
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It can be interpreted that the risk of ventilator Associated Pneumonia has not increased in 
the experimental after the implementation of comprehensive interventional package. 
Regarding the impact of comprehensive interventional package, the mean score for post-
test-2 was lower than the mean score for post-test-1. It was 2.3 in the post-test-1 and 2.13 in the 
post-test-2. The paired‘t’ test for the risk of Ventilator Associated Pneumonia was 5.38 
(p<0.001), which was highly significant. The independent ‘t’ test was 8.136 (p<0.001), which 
was highly significant. This was statistically proven that the impact of comprehensive 
interventional package on risk of Ventilator Associated Pneumonia was effective among 
mechanically ventilated patients. 
Regarding association between the pre-test risk of Ventilated Associated Pneumonia with 
the selected socio-demographic and clinical variables, there is no significant association between 
the risk of Ventilator Associated Pneumonia with the selected socio-demographic and clinical 
variables. 
Thus, the finding of this study provides an empirical evidence to prove that the 
implementation of comprehensive interventional package is a good method to prevent the risk of 
Ventilator Associated Pneumonia among the mechanically ventilated patients. 
LIMITATIONS 
1. The study is limited to identifying the risk of ventilator associated pneumonia among 
ventilated patients by modified clinical pulmonary infection score 
2. Patients who were mechanically intubated (more more than 12 hours at pre-test). 
3. Patients intubated in the same hospital and not the patients being intubated in other 
hospitals and brought for further management. 
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4. In this study, the data was collected from a small number of samples (60). 
IMPLICATIONS 
The findings of the study have several implications in the following field, it can be 
discussed on four areas namely. Nursing education, Nursing practice, Nursing administration and 
Nursing research. 
Implications in Nursing educations 
 This study has provided the important tool for preventing the risk of Ventilator 
Associated Pneumonia among mechanically ventilated patients through implementation 
of comprehensive interventional package. 
 The findings will help the nursing students to understand the need to be educated and 
create awareness regarding risk of Ventilator Associated Pneumonia. 
 It helps the nursing facilities to give more importance for planning and implementing 
comprehensive interventional package to prevent risk of Ventilator Associated 
Pneumonia. 
 Current research regarding risk of Ventilator Associated Pneumonia bestows an 
opportunity for nursing students about the need for awareness and knowledge regarding 
comprehensive interventional package. 
Implications in Nursing practice 
 The findings of the study will help the nurses to prevent risk of Ventilator Associated 
Pneumonia with the help of implementing comprehensive interventional package. 
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 The findings will help the nursing personnel to estimate the impact of comprehensive 
interventional package on risk of Ventilator Associated Pneumonia. 
 The nursing personnel will understand the necessity of gaining knowledge about 
comprehensive interventional package. 
 Nurses can utilize the knowledge regarding comprehensive interventional package in 
clinical practice. 
Implications in Nursing administration 
 The present study will help the nursing administrative authority to recognize the need for 
developing an appropriate educational program for college students. 
 Nurse as an administrator has a crucial role in planning the awareness program imparting 
information to nursing staffs and students. 
 Nursing administration must see that a separate budget should be allocated for in-service 
education in the nursing department. 
 Optimizing the knowledge on risk of Ventilator Associated Pneumonia among nurses 
will improve their professional knowledge as nursing world is always changing and 
challenging. 
Implications in Nursing research 
 The findings of the study will help to expand the scientific body of professional 
knowledge for further research. 
 Based on this study, in-depth research studies of various factors contribute for risk of 
Ventilator Associated Pneumonia prevention among diploma nurses and basis nursing 
degree holders. 
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 Large scale studies can be conducted in consideration of other contributing variables. 
CONCLUSION 
The main conclusion of this study shows that implementation of preventive care plays an 
important role in bringing changes in health conditions and reducing complications among 
mechanically ventilated patients. The investigator assures that every patient who had taken part 
in this study will be prevented from the risk of Ventilator Associated Pneumonia. 
RECOMMENDATIONS 
On the basis of the findings of this study, the following recommendation has been made 
for further studies. 
1. A similar study can be undertaken by utilizing other domain of advance nursing 
practices. 
2. A similar study can be undertaken with large number of samples which might lead to 
generalization. 
3. A similar study can be conducted in other settings. 
4. As per the results of the study, it is recommended that comprehensive interventional 
package can be encouraged to be carried out in clinical setting as a preventive 
approach for VAP in mechanically ventilated patients. 
5. It is also recommended to conduct further research studies to discover more effective 
strategies to prevent VAP among mechanically ventilated patients. 
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APPENDIX-A 
LETTER SEEKING EXPERTS OPINION FOR CONTENT 
VALIDITY 
From 
Mr. D. Deepak Stephen, 
II year M.sc (N), 
C.S.I. Jeyaraj Annapackiam College of Nursing and Allied Health sciences, 
Pasumalai, Madurai-4. 
 
To 
 
 
Respected sir/Madam, 
Sub: Requisition for opinions and suggestions of experts for content 
validity of the research tool. 
With due regards, I kindly bring to your valuable notice that , I am doing my 
post-graduation in nursing at C.S.I. Jeyaraj Annapackiam College of Nursing and 
Allied Health sciences, Madurai. As a part of my university requirement, I am 
supposed to complete a research study, for which I have selected the following topic, 
“Study to evaluate the impact of comprehensive interventional package to 
identify the risk of ventilator associated pneumonia among ventilated patients in 
selected hospital, Madurai” 
I am in need of your valuable opinions and suggestions regarding the tool 
which I have prepared. So I humbly request you to spare a little of your precious time 
to validate the tool, for which I remain ever grateful to you. 
                                                               Thanking you, 
Place: Pasumalai                                                                      Yours sincerely, 
Date:                                                                                        (D. Deepak Stephen)                                 
 
 
 
 
APPENDIX-B 
LETTER SEEKING PERMISSION TO CONDUCT THE PILOT 
STUDY 
From 
Mr. D. Deepak Stephen, 
II year M.sc (N), 
C.S.I. Jeyaraj Annapackiam College of Nursing and Allied Health sciences, 
Pasumalai, Madurai-4. 
 
To 
 
 
Forwarded through 
The principal, 
C.S.I. Jeyaraj Annapackiam College of Nursing and Allied Health sciences, 
Pasumalai, Madurai-4. 
 
Respected sir/Madam, 
Sub: Seeking permission to conduct the pilot study. 
With due regards, I kindly bring to your valuable notice that, I am a post 
graduate student of C.S.I. Jeyaraj Annapackiam College of Nursing and Allied 
Sciences, Madurai. As a part of my requirement I am supposed to complete a research 
study for which I have selected the following topic: 
“Study to evaluate the impact of comprehensive interventional package to 
identify the risk of ventilator associated pneumonia among ventilated patients in 
selected hospital, Madurai”  
I would like to do my study in your esteemed institution. So I humbly request 
you to give me permission to conduct the study for which I remain grateful. 
Thanking you in anticipation 
Place: Pasumalai,                                                                     Yours sincerely, 
Date:                                                                                        (D. Deepak Stephen)                                
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LETTER SEEKING PERMISSION TO CONDUCT THE 
RESEARCH STUDY 
From 
Mr. D. Deepak Stephen, 
II year M.sc (N), 
C.S.I. Jeyaraj Annapackiam College of Nursing and Allied Health sciences, 
Pasumalai, Madurai-4. 
 
To 
 
 
Forwarded through 
The principal, 
C.S.I. Jeyaraj Annapackiam College of Nursing and Allied Health sciences, 
Pasumalai, Madurai-4. 
 
Respected sir/Madam, 
Sub: Seeking permission to conduct the research study. 
With due regards, I kindly bring to your valuable notice that, I am a post 
graduate student of C.S.I. Jeyaraj Annapackiam College of Nursing and Allied 
Sciences, Madurai. As a part of my requirement I am supposed to complete a research 
study for which I have selected the following topic: 
“Study to evaluate the impact of comprehensive interventional package to 
identify the risk of ventilator associated pneumonia among ventilated patients in 
selected hospital, Madurai”  
I would like to do my study in your esteemed institution. So I humbly request you to 
give me permission to conduct the study for which I remain grateful. 
                                             Thanking you in anticipation 
Place: Pasumalai,                                                                     Yours sincerely, 
Date:                                                                                        (D. Deepak Stephen) 
 
 
APPENDIX-D 
CERTIFICATE OF VALIDATION 
 
This is to certify that the tool developed by Mr. D. Deepak Stephen M.Sc (N) 
II year student of C.S.I. Jeyaraj Annapackiam College of Nursing, Pasumalai, 
Madurai.(Affiliated to the Tamil Nadu Dr.M.G.R. Medical University, Chennai) is 
validated by the undersigned, can proceed with this tool and conduct the main study 
for dissertation entitled, 
“Study to evaluate the impact of comprehensive interventional package to 
identify the risk of ventilator associated pneumonia among ventilated patients in 
selected hospital, Madurai” 
 
 
 
Place:        Signature: 
Date:        Name: 
        Designation: 
        Address: 
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1. Dr. Mr. Jayanthnath. R., M.B.B.S., M.D., 
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2. Prof. Dr. Mrs. Jasmine Parimala. P., M.Sc(N).,Ph.D., 
H.O.D of Medical Surgical Nursing Department 
Caldwell College of nursing, 
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3. Mrs. Suguna Doraisamy., R.N.R.M., 
Assistant Matron 
C.R.P.F Composite Hospital 
Pallipuram, Trivandrum-16. 
 
4. Prof. Dr. Mrs. Jaya Thanga Selvi., M.Sc(N).,Ph.D., 
H.O.D of Medical Surgical Nursing Department 
C.S.I. Jeyaraj Annapackiam College of Nursing and Allied Sciences, 
Pasumalai, Madurai – 04 
     
5. Prof. Dr. Mr. John Sam Arun Prabu.Y., M.Sc(N).,Ph.D., 
H.O.D of Community Health Nursing Department 
C.S.I. Jeyaraj Annapackiam College of Nursing and Allied Sciences, 
Pasumalai, Madurai – 04 
 
6. Prof. Mrs. Shanthi. P., M.Sc(N).,(Ph.D)., 
H.O.D of Maternal Health Nursing Department 
C.S.I. Jeyaraj Annapackiam College of Nursing and Allied Sciences, 
Pasumalai, Madurai – 04 
 
7. Prof. Dr. Mrs. Jessie Metilda. N., M.Sc(N).,Ph.D., 
H.O.D of Child Health Nursing Department 
C.S.I. Jeyaraj Annapackiam College of Nursing and Allied Sciences, 
Pasumalai, Madurai – 04 
 
8. Prof. Dr. Mrs. Jancy Rachel Daisy. R., M.Sc(N).,Ph.D., 
H.O.D of Mental Health Nursing Department 
C.S.I. Jeyaraj Annapackiam College of Nursing and Allied Sciences, 
Pasumalai, Madurai – 04 
 
9. Mrs. Vijaya Suresh. M., M.Sc(N)., 
Assistant Professor in Medical-Surgical Nursing Department 
C.S.I. Jeyaraj Annapackiam College of Nursing and Allied Sciences, 
Pasumalai, Madurai – 04 
 
10. Mrs. Anbu Roseline. A., M.Sc(N).,(Ph.D)., 
Assistant Professor in Medical-Surgical Nursing Department 
C.S.I. Jeyaraj Annapackiam College of Nursing and Allied Sciences, 
Pasumalai, Madurai – 04 
 
11. Mrs. Jeya Jothi. P., M.Sc(N)., 
Assistant Professor in Medical-Surgical Nursing Department 
C.S.I. Jeyaraj Annapackiam College of Nursing and Allied Sciences, 
Pasumalai, Madurai – 04 
12. Mrs. Pricilla. K., M.Sc(N)., 
Assistant Professor in Medical-Surgical Nursing Department 
C.S.I. Jeyaraj Annapackiam College of Nursing and Allied Sciences, 
Pasumalai, Madurai – 04 
 
13. Mrs. DhanaPriya.G., M.Sc(N)., 
Lecturer in Medical-Surgical Nursing Department 
C.S.I. Jeyaraj Annapackiam College of Nursing and Allied Sciences, 
Pasumalai, Madurai – 04 
 
14. Mrs. Sasikala. P., M.Sc(N)., 
Lecturer in Medical-Surgical Nursing Department 
C.S.I. Jeyaraj Annapackiam College of Nursing and Allied Sciences, 
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RESEARCH TOOL 
I. Demographic variables 
1. Age in years 
a) 20-30 
b) 31-40 
c) 41-50 
d) 51-60 
2. Gender 
a) Male  
b) Female 
3. Educational status 
a) Illiterate 
b) Literate 
4. Income (per month) 
a) 1000-4000 
b) 4001-8000 
c) 8001-12000 
d) Above 12000 
5. Marital status 
a) Married  
b) Unmarried 
 
6. Occupation 
a) Coolie 
b) Private employee 
c) Government employee 
d) House wife 
e) Retired 
II. Clinical Variables 
1. Personal habit of 
a) Smoking  
b) Alcoholism 
c) Both smoking and alcoholism 
2. Known history of 
a) Pulmonary infection 
b) Neurological disorder 
c) Systemic infection 
3. Glasgow coma scale 
a) 13-15 
b) 8-12 
c) Less than 8 (<8) 
4. Use of anesthetics drug 
a) Relaxant drug 
b) Sedation drug 
c) Both relaxant and sedation drug 
5. Group of antibiotics receiving 
a) Narrow spectrum 
b) Broad spectrum 
c) Both narrow and broad spectrum 
6. Administration of prophylactic drug for peptic ulcer disease 
a) Sucralfate (Antacid) 
b) Pantoprazole (proton pump inhibitor) 
c) Ranitidine (H2 receptor blockers) 
7. Type of diagnosis 
a) Neurologic disorder 
b) Respiratory disorder 
c) Trauma 
d) Cardiovascular disorder 
e) Poisoning 
f) Others 
8. Reason for intubation 
a) Respiratory failure 
b) Airway protection 
c) Hemodynamic instability 
9. Type of intubation 
a) Emergency intubation 
b) Elective intubation 
RISK ASSESSMENT TOOL FOR VAP 
S.No PARAMETERS NORMAL FINDINGS (0) 
DEVIATED FINDINGS 
(1) 
I. Temperature (0F) Less than 99
0F 
(<99) 
More than 990F 
(>99) 
 
Tracheal secretion Nil or rare More with or without purulent 
Leukocytes 
count(mm3) 
More than 4,000 and less 
than 11,000 
(>4,000 and <11,000) 
Less than 4,000 or more than 
11,000 
(<4,000 or >11,000) 
II. Glasgow coma scale More than 8 (>8) 
8 or less than 8 
(≤8) 
III. Respiratory rate (breath/min) 12-20 breath/min More than 20 breath/min (>20) 
 
Respiratory pattern Normal respiratory effort 
Rapid breathing, breathing 
with use of assessory chest 
wall muscles 
Breathing sound Normal breath sound Wheeze or crackle 
Spo2 (%) 
90 or more than 90% 
(≥90) 
Less than 90% 
(<90) 
ABG Analysis (Pao2) 
More than 240 mmHg 
(>240) 
Less than 240 mmHg 
(<240) 
Fio2 level (%) 
60% or less than 60% 
(≤60) More than 60% (>60) 
 
SCORING KEY 
0: No risk 
1-3: Mild risk 
4-8: Moderate risk 
9-10: High risk 
